Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
PLoS One
    January 2021
  1. MOUSTAFA D, Elwahed MRA, Elsaid HH, Parvin JD, et al
    Modulation of Early Mitotic Inhibitor 1 (EMI1) depletion on the sensitivity of PARP inhibitors in BRCA1 mutated triple-negative breast cancer cells.
    PLoS One. 2021;16:e0235025.
    >> Share

  2. GALILI B, Tekpli X, Kristensen VN, Yakhini Z, et al
    Efficient gene expression signature for a breast cancer immuno-subtype.
    PLoS One. 2021;16:e0245215.
    >> Share

  3. BHANDARI D, Shibanuma A, Kiriya J, Hirachan S, et al
    Factors associated with breast cancer screening intention in Kathmandu Valley, Nepal.
    PLoS One. 2021;16:e0245856.
    >> Share

  4. ALLMAN R, Spaeth E, Lai J, Gross SJ, et al
    A streamlined model for use in clinical breast cancer risk assessment maintains predictive power and is further improved with inclusion of a polygenic risk score.
    PLoS One. 2021;16:e0245375.
    >> Share

  5. SAFI N, Saunders C, Hayen A, Anazodo A, et al
    Gestational breast cancer in New South Wales: A population-based linkage study of incidence, management, and outcomes.
    PLoS One. 2021;16:e0245493.
    >> Share

  6. ELLINGJORD-DALE M, Papadimitriou N, Katsoulis M, Yee C, et al
    Coffee consumption and risk of breast cancer: A Mendelian randomization study.
    PLoS One. 2021;16:e0236904.
    >> Share

  7. SALGUERO-ARANDA C, Sancho-Mensat D, Canals-Lorente B, Sultan S, et al
    Expression of Concern: STAT6 knockdown using multiple siRNA sequences inhibits proliferation and induces apoptosis of human colorectal and breast cancer cell lines.
    PLoS One. 2021;16:e0246415.
    >> Share

  8. NIEF C, Morhard R, Chelales E, Adrianzen Alvarez D, et al
    Polymer-assisted intratumoral delivery of ethanol: Preclinical investigation of safety and efficacy in a murine breast cancer model.
    PLoS One. 2021;16:e0234535.
    >> Share

  9. BOUJEMAA M, Hamdi Y, Mejri N, Romdhane L, et al
    Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia.
    PLoS One. 2021;16:e0245362.
    >> Share

  10. CHIN CH, Tseng LM, Chao TC, Wang TJ, et al
    Self-care as a mediator between symptom-management self-efficacy and quality of life in women with breast cancer.
    PLoS One. 2021;16:e0246430.
    >> Share

  11. XU S, Wang H, Liu Y, Zhang C, et al
    Hair chemicals may increase breast cancer risk: A meta-analysis of 210319 subjects from 14 studies.
    PLoS One. 2021;16:e0243792.
    >> Share

  12. OLIVEIRA NPD, Cancela MC, Martins LFL, de Souza DLB, et al
    Spatial distribution of advanced stage diagnosis and mortality of breast cancer: Socioeconomic and health service offer inequalities in Brazil.
    PLoS One. 2021;16:e0246333.
    >> Share

  13. ZHOU Y, Yuan Y, Li L, Wang X, et al
    HER2-intronic miR-4728-5p facilitates HER2 expression and accelerates cell proliferation and migration by targeting EBP1 in breast cancer.
    PLoS One. 2021;16:e0245832.
    >> Share

  14. HONG JH, Goo JM, Moon HG, Chang JM, et al
    Usefulness of staging chest-CT in patients with operable breast cancer.
    PLoS One. 2021;16:e0246563.
    >> Share

  15. BAR H, Bang S
    A mixture model to detect edges in sparse co-expression graphs with an application for comparing breast cancer subtypes.
    PLoS One. 2021;16:e0246945.
    >> Share

  16. ZHANG H, Zhang LQ, Yang CC, Li J, et al
    The high expression of NUDT5 indicates poor prognosis of breast cancer by modulating AKT / Cyclin D signaling.
    PLoS One. 2021;16:e0245876.
    >> Share

  17. SCIMONE MT, Krishnamurthy S, Maguluri G, Preda D, et al
    Assessment of breast cancer surgical margins with multimodal optical microscopy: A feasibility clinical study.
    PLoS One. 2021;16:e0245334.
    >> Share

  18. YANAI H, Yoshikawa K, Ishida M, Tsuta K, et al
    Presence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer: Results from a retrospective single-center study.
    PLoS One. 2021;16:e0245725.
    >> Share

  19. ASADI M, Ahmadi N, Ahmadvand S, Jafari AA, et al
    Investigation of olfactory receptor family 51 subfamily j member 1 (OR51J1) gene susceptibility as a potential breast cancer-associated biomarker.
    PLoS One. 2021;16:e0246752.
    >> Share

  20. PHAM DX, Ho TH, Bui TD, Ho-Pham LT, et al
    Trends in breast cancer incidence in Ho Chi Minh City 1996-2015: A registry-based study.
    PLoS One. 2021;16:e0246800.
    >> Share

  21. JACKSON C, Freeman ALJ, Szlamka Z, Spiegelhalter DJ, et al
    The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis.
    PLoS One. 2021;16:e0246441.
    >> Share

  22. SANDOVAL RL, Leite ACR, Barbalho DM, Assad DX, et al
    Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis.
    PLoS One. 2021;16:e0247363.
    >> Share

  23. NAFIE E, Lolarga J, Lam B, Guo J, et al
    Harmine inhibits breast cancer cell migration and invasion by inducing the degradation of Twist1.
    PLoS One. 2021;16:e0247652.
    >> Share

  24. WANANDI SI, Limanto A, Yunita E, Syahrani RA, et al
    Correction: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells.
    PLoS One. 2021;16:e0247694.
    >> Share

  25. AL-SALEH K, Salah T, Arafah M, Husain S, et al
    Prognostic significance of estrogen, progesterone and HER2 receptors' status conversion following neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from a tertiary Cancer Center in Saudi Arabia.
    PLoS One. 2021;16:e0247802.
    >> Share

  26. LUO HB, Liu YY, Wang CH, Qing HM, et al
    Radiomic features of axillary lymph nodes based on pharmacokinetic modeling DCE-MRI allow preoperative diagnosis of their metastatic status in breast cancer.
    PLoS One. 2021;16:e0247074.
    >> Share

  27. OLSEN KS, Holden M, Thalabard JC, Rasmussen Busund LT, et al
    Global blood gene expression profiles following a breast cancer diagnosis-Clinical follow-up in the NOWAC post-genome cohort.
    PLoS One. 2021;16:e0246650.
    >> Share

  28. RAHIMZADEH S, Burczynska B, Ahmadvand A, Sheidaei A, et al
    Geographical and socioeconomic inequalities in female breast cancer incidence and mortality in Iran: A Bayesian spatial analysis of registry data.
    PLoS One. 2021;16:e0248723.
    >> Share

  29. GRANQVIST V, Holmgren C, Larsson C
    Induction of interferon-beta and interferon signaling by TRAIL and Smac mimetics via caspase-8 in breast cancer cells.
    PLoS One. 2021;16:e0248175.
    >> Share

  30. UMAMAHESWARAN G, Kadambari D, Muthuvel SK, Kumar NAN, et al
    Polymorphisms of T- cell leukemia 1A gene loci are not related to the development of adjuvant letrozole-induced adverse events in breast cancer.
    PLoS One. 2021;16:e0247989.
    >> Share

  31. LOURO J, Roman M, Posso M, Vazquez I, et al
    Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening.
    PLoS One. 2021;16:e0248930.
    >> Share

  32. KOOP Y, Dobbe L, Maas AHEM, van Spronsen DJ, et al
    Oncology professionals' perspectives towards cardiac surveillance in breast cancer patients with high cardiotoxicity risk: A qualitative study.
    PLoS One. 2021;16:e0249067.
    >> Share

  33. GONG Z, Chen J, Wang J, Liu S, et al
    Differential methylation and expression patterns of microRNAs in relation to breast cancer subtypes among American women of African and European ancestry.
    PLoS One. 2021;16:e0249229.
    >> Share

  34. KLINGEN TA, Chen Y, Aas H, Wik E, et al
    Fibulin-2 expression associates with vascular invasion and patient survival in breast cancer.
    PLoS One. 2021;16:e0249767.
    >> Share

  35. MADUT A, Fuchsova V, Man H, Askar S, et al
    Increased prevalence of obstructive sleep apnea in women diagnosed with endometrial or breast cancer.
    PLoS One. 2021;16:e0249099.
    >> Share

  36. AGUIRRE-CAMACHO A, Hidalgo B, Gonzalez-Cuevas G
    Fear of breast cancer among young Spanish women: Factor structure and psychometric properties of the Champion breast cancer fear scale.
    PLoS One. 2021;16:e0249562.
    >> Share

  37. LI J, Zhou Z, Dong J, Fu Y, et al
    Predicting breast cancer 5-year survival using machine learning: A systematic review.
    PLoS One. 2021;16:e0250370.
    >> Share

  38. CHAINITIKUN S, Espinosa Fernandez JR, Long JP, Iwase T, et al
    Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review.
    PLoS One. 2021;16:e0250057.
    >> Share

    CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells.
    PLoS One. 2021;16:e0246264.
    >> Share

  40. NISHIDA-FUKUDA H, Tokuhiro K, Ando Y, Matsushita H, et al
    Evaluation of the antiproliferative effects of the HASPIN inhibitor CHR-6494 in breast cancer cell lines.
    PLoS One. 2021;16:e0249912.
    >> Share

  41. NERSISYAN S, Galatenko A, Galatenko V, Shkurnikov M, et al
    miRGTF-net: Integrative miRNA-gene-TF network analysis reveals key drivers of breast cancer recurrence.
    PLoS One. 2021;16:e0249424.
    >> Share

  42. SATPATHY S, Patra A, Hussain MD, Kazi M, et al
    A fraction of Pueraria tuberosa extract, rich in antioxidant compounds, alleviates ovariectomized-induced osteoporosis in rats and inhibits growth of breast and ovarian cancer cells.
    PLoS One. 2021;16:e0240068.
    >> Share

  43. HSIANG YP, Wang YT, Huang KS, Huang TY, et al
    Facile production of chlorophyllides using recombinant CrCLH1 and their cytotoxicity towards multidrug resistant breast cancer cell lines.
    PLoS One. 2021;16:e0250565.
    >> Share

  44. YANG C, He XF
    Evaluation of association studies and a systematic review and meta-analysis of CYP1A1 T3801C and A2455G polymorphisms in breast cancer risk.
    PLoS One. 2021;16:e0249632.
    >> Share

  45. AHMED SH, Espinoza-Sanchez NA, El-Damen A, Fahim SA, et al
    Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer.
    PLoS One. 2021;16:e0250642.
    >> Share

  46. HO PJ, Yeoh YS, Miao H, Lim SH, et al
    Cohort profile: The Singapore Breast Cancer Cohort (SGBCC), a multi-center breast cancer cohort for evaluation of phenotypic risk factors and genetic markers.
    PLoS One. 2021;16:e0250102.
    >> Share

  47. TOKUNAGA H, Iida K, Hozawa A, Ogishima S, et al
    Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).
    PLoS One. 2021;16:e0236907.
    >> Share

  48. HOLTDIRK F, Mehnert A, Weiss M, Mayer J, et al
    Results of the Optimune trial: A randomized controlled trial evaluating a novel Internet intervention for breast cancer survivors.
    PLoS One. 2021;16:e0251276.
    >> Share

  49. VIJAYASARVESWARI V, Andrew AM, Jusoh M, Ahmad RB, et al
    Correction: Multi-stage feature selection (MSFS) algorithm for UWB-based early breast cancer size prediction.
    PLoS One. 2021;16:e0251679.
    >> Share

  50. ELOBAID Y, Aamir M, Grivna M, Suliman A, et al
    Breast cancer survival and its prognostic factors in the United Arab Emirates: A retrospective study.
    PLoS One. 2021;16:e0251118.
    >> Share

  51. PILLAI SG, Siddappa CM, Ma C, Snider J, et al
    A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients.
    PLoS One. 2021;16:e0246139.
    >> Share

  52. SAKATA-MATSUZAWA M, Denda-Nagai K, Fujihira H, Noji M, et al
    Glycans unique to the relapse-prone subset within triple-negative breast cancer as revealed by lectin array-based analysis of surgical specimens.
    PLoS One. 2021;16:e0250747.
    >> Share

  53. CHA YJ, Kim D, Bae SJ, Ahn SG, et al
    The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients.
    PLoS One. 2021;16:e0250986.
    >> Share

  54. RAGO M, Placidi L, Polsoni M, Rambaldi G, et al
    Evaluation of a generalized knowledge-based planning performance for VMAT irradiation of breast and locoregional lymph nodes-Internal mammary and/or supraclavicular regions.
    PLoS One. 2021;16:e0245305.
    >> Share

  55. YAMAMURO M, Asai Y, Hashimoto N, Yasuda N, et al
    The effect of breast density on the missed lesion rate in screening digital mammography determined using an adjustable-density breast phantom tailored to Japanese women.
    PLoS One. 2021;16:e0245060.
    >> Share

  56. LEE SB, Kim H, Kim J, Chung IY, et al
    Prognosis according to clinical and pathologic lymph node status in breast cancer patients who underwent sentinel lymph node biopsy alone after neoadjuvant therapy.
    PLoS One. 2021;16:e0251597.
    >> Share

  57. MA S, Shepard DS, Ritter GA, Martell RE, et al
    Cost sharing for breast cancer hormone therapy: How do dual eligible patients' copayment impact adherence.
    PLoS One. 2021;16:e0250967.
    >> Share

  58. VELAZQUEZ FN, Zhang L, Viscardi V, Trocchia C, et al
    Loss of sphingosine kinase 1 increases lung metastases in the MMTV-PyMT mouse model of breast cancer.
    PLoS One. 2021;16:e0252311.
    >> Share

  59. KIM HS, Kim MG, Min KW, Jung US, et al
    High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer.
    PLoS One. 2021;16:e0252052.
    >> Share

  60. NG DY, Tudor Car L, Ng MJM, Lu J, et al
    Identifying barriers to early presentation in patients with locally advanced breast cancer (LABC) in Northern Singapore: Qualitative study.
    PLoS One. 2021;16:e0252008.
    >> Share

  61. YOSHIKAWA K, Ishida M, Yanai H, Tsuta K, et al
    Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients.
    PLoS One. 2021;16:e0253176.
    >> Share

  62. LEE J, Kang BJ, Kim SH
    Usefulness of postoperative surveillance MR for women after breast-conservation therapy: Focusing on MR features of early and late recurrent breast cancer.
    PLoS One. 2021;16:e0252476.
    >> Share

  63. AKLILU S, Bain C, Bansil P, de Sanjose S, et al
    Evaluation of diagnostic ultrasound use in a breast cancer detection strategy in Northern Peru.
    PLoS One. 2021;16:e0252902.
    >> Share

  64. PODUVAL D, Sichmanova Z, Straume AH, Lonning PE, et al
    Correction: The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer.
    PLoS One. 2021;16:e0253361.
    >> Share

  65. KANG Z, Chen S, Shi L, He Y, et al
    Predictors of heart and lung dose in left-sided breast cancer treated with VMAT relative to 3D-CRT: A retrospective study.
    PLoS One. 2021;16:e0252552.
    >> Share

  66. WATANABE T, Oba T, Tanimoto K, Shibata T, et al
    Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer.
    PLoS One. 2021;16:e0252822.
    >> Share

  67. AL-KEILANI MS, Elstaty RI, Alqudah MA, Alkhateeb AM, et al
    Immunohistochemical expression of substance P in breast cancer and its association with prognostic parameters and Ki-67 index.
    PLoS One. 2021;16:e0252616.
    >> Share

  68. ZHU L, Cui K, Weng L, Yu P, et al
    A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells.
    PLoS One. 2021;16:e0249174.
    >> Share

  69. DING H, Buzzard GW, Huang S, Sehorn MG, et al
    MICA-G129R: A bifunctional fusion protein increases PRLR-positive breast cancer cell death in co-culture with natural killer cells.
    PLoS One. 2021;16:e0252662.
    >> Share

  70. Retraction: AIB1 Cooperates with ERalpha to Promote Epithelial Mesenchymal Transition in Breast Cancer through SNAI1 Activation.
    PLoS One. 2021;16:e0252791.
    >> Share

  71. OSEI-AFRIYIE S, Addae AK, Oppong S, Amu H, et al
    Breast cancer awareness, risk factors and screening practices among future health professionals in Ghana: A cross-sectional study.
    PLoS One. 2021;16:e0253373.
    >> Share

  72. HSU SN, Hui EWE, Liu M, Wu D, et al
    Revealing nuclear receptor hub modules from Basal-like breast cancer expression networks.
    PLoS One. 2021;16:e0252901.
    >> Share

  73. SALAS M, Henderson M, Sundararajan M, Tu N, et al
    Use of comorbidity indices in patients with any cancer, breast cancer, and human epidermal growth factor receptor-2-positive breast cancer: A systematic review.
    PLoS One. 2021;16:e0252925.
    >> Share

  74. ALMUHTASEB MIA, Alby F, Zucchermaglio C, Fatigante M, et al
    Social support for breast cancer patients in the occupied Palestinian territory.
    PLoS One. 2021;16:e0252608.
    >> Share

  75. WIELEMA M, Sijens PE, Dijkstra H, De Bock GH, et al
    Diffusion weighted imaging of the breast: Performance of standardized breast tumor tissue selection methods in clinical decision making.
    PLoS One. 2021;16:e0245930.
    >> Share

  76. VIVES N, Farre A, Ibanez-Sanz G, Vidal C, et al
    Text messaging as a tool to improve cancer screening programs (M-TICS Study): A randomized controlled trial protocol.
    PLoS One. 2021;16:e0245806.
    >> Share

  77. LI Z, Zhang J, Zou W, Xu Q, et al
    The methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism is associated with breast cancer subtype susceptibility in southwestern China.
    PLoS One. 2021;16:e0254267.
    >> Share

  78. KENNEY J, Ndoye A, Lamar JM, DiPersio CM, et al
    Comparative use of CRISPR and RNAi to modulate integrin alpha3beta1 in triple negative breast cancer cells reveals that some pro-invasive/pro-metastatic alpha3beta1 functions are independent of global regulation of the transcriptome.
    PLoS One. 2021;16:e0254714.
    >> Share

  79. YANG J, Virostko J, Hormuth DA 2nd, Liu J, et al
    An experimental-mathematical approach to predict tumor cell growth as a function of glucose availability in breast cancer cell lines.
    PLoS One. 2021;16:e0240765.
    >> Share

  80. KIM H, Kwon S, Son SM, Jeong E, et al
    Tailored approach to the choice of long-term vascular access in breast cancer patients.
    PLoS One. 2021;16:e0255004.
    >> Share

  81. LOTHONG M, Sakares W, Rojsitthisak P, Tanikawa C, et al
    Collagen XVII inhibits breast cancer cell proliferation and growth through deactivation of the AKT/mTOR signaling pathway.
    PLoS One. 2021;16:e0255179.
    >> Share

  82. RATH S, Elamarthi P, Parab P, Gulia S, et al
    Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice.
    PLoS One. 2021;16:e0253722.
    >> Share

  83. KING L, Flaus A, Holian E, Golden A, et al
    Survival outcomes are associated with genomic instability in luminal breast cancers.
    PLoS One. 2021;16:e0245042.
    >> Share

  84. KIM JJ, Liang W, Kang CC, Pegram MD, et al
    Single-cell immunoblotting resolves estrogen receptor-alpha isoforms in breast cancer.
    PLoS One. 2021;16:e0254783.
    >> Share

  85. AHMED F, Adnan M, Malik A, Tariq S, et al
    Perception of breast cancer risk factors: Dysregulation of TGF-beta/miRNA axis in Pakistani females.
    PLoS One. 2021;16:e0255243.
    >> Share

    January 2020
  86. JAMSHIDII N, Chang J, Mock K, Nguyen B, et al
    Evaluation of the predictive ability of ultrasound-based assessment of breast cancer using BI-RADS natural language reporting against commercial transcriptome-based tests.
    PLoS One. 2020;15:e0226634.
    >> Share

  87. PERRIER A, Boelle PY, Chretien Y, Gligorov J, et al
    An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies.
    PLoS One. 2020;15:e0227356.
    >> Share

  88. WANG Q, Liu X, Ren S
    Tofu intake is inversely associated with risk of breast cancer: A meta-analysis of observational studies.
    PLoS One. 2020;15:e0226745.
    >> Share

  89. GRESNER P, Jablonska E, Gromadzinska J
    Rad51 paralogs and the risk of unselected breast cancer: A case-control study.
    PLoS One. 2020;15:e0226976.
    >> Share

  90. AL-WAJEEH AS, Salhimi SM, Al-Mansoub MA, Khalid IA, et al
    Comparative proteomic analysis of different stages of breast cancer tissues using ultra high performance liquid chromatography tandem mass spectrometer.
    PLoS One. 2020;15:e0227404.
    >> Share

  91. SHAMSI U, Khan S, Azam I, Habib Khan A, et al
    A multicenter case control study of association of vitamin D with breast cancer among women in Karachi, Pakistan.
    PLoS One. 2020;15:e0225402.
    >> Share

  92. ROJAS L, Muniz S, Medina L, Pena J, et al
    Cost-minimization analysis of subcutaneous versus intravenous trastuzumab administration in Chilean patients with HER2-positive early breast cancer.
    PLoS One. 2020;15:e0227961.
    >> Share

  93. FERREIRA LC, Orso F, Dettori D, Lacerda JZ, et al
    The role of melatonin on miRNAs modulation in triple-negative breast cancer cells.
    PLoS One. 2020;15:e0228062.
    >> Share

  94. TFAILY MA, Nassar F, Sellam LS, Amir-Tidadini ZC, et al
    miRNA expression in advanced Algerian breast cancer tissues.
    PLoS One. 2020;15:e0227928.
    >> Share

  95. CHENG HG, Gonzalez-Reymundez A, Li I, Pathak A, et al
    Breast cancer survival and the expression of genes related to alcohol drinking.
    PLoS One. 2020;15:e0228957.
    >> Share

  96. JAMSHIDI N, Chang J, Mock K, Nguyen B, et al
    Correction: Evaluation of the predictive ability of ultrasound-based assessment of breast cancer using BI-RADS natural language reporting against commercial transcriptome-based tests.
    PLoS One. 2020;15:e0229584.
    >> Share

  97. LEE S, Liang X, Woods M, Reiner AS, et al
    Machine learning on genome-wide association studies to predict the risk of radiation-associated contralateral breast cancer in the WECARE Study.
    PLoS One. 2020;15:e0226157.
    >> Share

  98. MU Q, Yu J, Griffin JI, Wu Y, et al
    Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis.
    PLoS One. 2020;15:e0228557.
    >> Share

  99. LI M, Han M, Chen Z, Tang Y, et al
    Does marital status correlate with the female breast cancer risk? A systematic review and meta-analysis of observational studies.
    PLoS One. 2020;15:e0229899.
    >> Share

  100. RATH M, Li Q, Li H, Lindstrom S, et al
    Correction: Evaluation of significant genome-wide association studies risk-SNPs in young breast cancer patients.
    PLoS One. 2020;15:e0230529.
    >> Share

  101. AN YY, Kim SH, Kang BJ, Suh YJ, et al
    Feasibility of abbreviated magnetic resonance imaging (AB-MRI) screening in women with a personal history (PH) of breast cancer.
    PLoS One. 2020;15:e0230347.
    >> Share

  102. KUSI G, Boamah Mensah AB, Boamah Mensah K, Dzomeku VM, et al
    Caregiving motivations and experiences among family caregivers of patients living with advanced breast cancer in Ghana.
    PLoS One. 2020;15:e0229683.
    >> Share

  103. VILLARREAL-GARZA C, Lopez-Martinez EA, Deneken-Hernandez Z, Maffuz-Aziz A, et al
    Change in therapeutic management after the EndoPredict assay in a prospective decision impact study of Mexican premenopausal breast cancer patients.
    PLoS One. 2020;15:e0228884.
    >> Share

  104. MIAO LF, Ye XH, He XF
    Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on breast cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.
    PLoS One. 2020;15:e0216147.
    >> Share

  105. HE TF, Yost SE, Frankel PH, Dagis A, et al
    Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis.
    PLoS One. 2020;15:e0229955.
    >> Share

  106. KIM YS, Sun S, Yoon JS, Ko YH, et al
    Clinical implications of APOBEC3A and 3B expression in patients with breast cancer.
    PLoS One. 2020;15:e0230261.
    >> Share

  107. KALLARACKAL J, Burger F, Bianco S, Romualdi A, et al
    A 3-gene biomarker signature to predict response to taxane-based neoadjuvant chemotherapy in breast cancer.
    PLoS One. 2020;15:e0230313.
    >> Share

  108. Retraction: Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pat
    PLoS One. 2020;15:e0231282.
    >> Share

  109. MARTINO G, Catalano A, Agostino RM, Bellone F, et al
    Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer.
    PLoS One. 2020;15:e0230681.
    >> Share

  110. LE DU F, Fujii T, Kida K, Davis DW, et al
    EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream(R) in patients with breast cancer treated with primary systemic therapy.
    PLoS One. 2020;15:e0229903.
    >> Share

  111. LEE SB, Bose S, Ahn SH, Son BH, et al
    Breast cancer diagnosis by analysis of serum N-glycans using MALDI-TOF mass spectroscopy.
    PLoS One. 2020;15:e0231004.
    >> Share

  112. SCHNEIDER PP, Pouwels XGLV, Passos VL, Ramaekers BLT, et al
    Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands.
    PLoS One. 2020;15:e0230909.
    >> Share

  113. SMEDA M, Kij A, Proniewski B, Matyjaszczyk-Gwarda K, et al
    Unexpected effects of long-term treatment with acetylsalicylic acid on late phase of pulmonary metastasis in murine model of orthotopic breast cancer.
    PLoS One. 2020;15:e0230520.
    >> Share

  114. BEAUCHAMP A, Mohebbi M, Cooper A, Pridmore V, et al
    The impact of translated reminder letters and phone calls on mammography screening booking rates: Two randomised controlled trials.
    PLoS One. 2020;15:e0226610.
    >> Share

  115. TUTZAUER J, Sjostrom M, Bendahl PO, Ryden L, et al
    Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer.
    PLoS One. 2020;15:e0231786.
    >> Share

  116. PALMER ACS, Zortea M, Souza A, Santos V, et al
    Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial.
    PLoS One. 2020;15:e0231379.
    >> Share

  117. ZHANG H, Luo M, Liang X, Wang D, et al
    Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer.
    PLoS One. 2020;15:e0232166.
    >> Share

  118. DING Y, Ding K, Qian H, Yu X, et al
    Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer.
    PLoS One. 2020;15:e0231895.
    >> Share

  119. KOROLKOVA OY, Widatalla SE, Whalen DS, Nangami GN, et al
    Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets.
    PLoS One. 2020;15:e0231711.
    >> Share

  120. PURRINGTON KS, Knight J 3rd, Dyson G, Ali-Fehmi R, et al
    CLCA2 expression is associated with survival among African American women with triple negative breast cancer.
    PLoS One. 2020;15:e0231712.
    >> Share

  121. ADAM A, Koranteng F
    Availability, accessibility, and impact of social support on breast cancer treatment among breast cancer patients in Kumasi, Ghana: A qualitative study.
    PLoS One. 2020;15:e0231691.
    >> Share

  122. HSU PC, Kadlubar SA, Siegel ER, Rogers LJ, et al
    Genome-wide DNA methylation signatures to predict pathologic complete response from combined neoadjuvant chemotherapy with bevacizumab in breast cancer.
    PLoS One. 2020;15:e0230248.
    >> Share

  123. PODUVAL D, Sichmanova Z, Straume AH, Lonning PE, et al
    The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer.
    PLoS One. 2020;15:e0225357.
    >> Share

  124. DOBROSSY B, Girasek E, Susanszky A, Koncz Z, et al
    "Clicks, likes, shares and comments" a systematic review of breast cancer screening discourse in social media.
    PLoS One. 2020;15:e0231422.
    >> Share

  125. WETSTEIN SC, Onken AM, Luffman C, Baker GM, et al
    Deep learning assessment of breast terminal duct lobular unit involution: Towards automated prediction of breast cancer risk.
    PLoS One. 2020;15:e0231653.
    >> Share

  126. EIRIKSSON FF, Nohr MK, Costa M, Bodvarsdottir SK, et al
    Lipidomic study of cell lines reveals differences between breast cancer subtypes.
    PLoS One. 2020;15:e0231289.
    >> Share

  127. PAMPHLETT R, Satgunaseelan L, Kum Jew S, Doble PA, et al
    Elemental bioimaging shows mercury and other toxic metals in normal breast tissue and in breast cancers.
    PLoS One. 2020;15:e0228226.
    >> Share

  128. HUANG BARTLETT C, Mardekian J, Cotter MJ, Huang X, et al
    Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer.
    PLoS One. 2020;15:e0227256.
    >> Share

  129. BOZEK A, Jarzab J, Mielnik M, Bogacz A, et al
    Can atopy have a protective effect against cancer?
    PLoS One. 2020;15:e0226950.
    >> Share

  130. ELLMANN S, Wenkel E, Dietzel M, Bielowski C, et al
    Implementation of machine learning into clinical breast MRI: Potential for objective and accurate decision-making in suspicious breast masses.
    PLoS One. 2020;15:e0228446.
    >> Share

  131. ESPINOSA FERNANDEZ JR, Eckhardt BL, Lee J, Lim B, et al
    Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research.
    PLoS One. 2020;15:e0231953.
    >> Share

  132. PAL CHOUDHURY P, Maas P, Wilcox A, Wheeler W, et al
    iCARE: An R package to build, validate and apply absolute risk models.
    PLoS One. 2020;15:e0228198.
    >> Share

  133. LI M, Yue C, Zuo X, Jin G, et al
    The effect of interleukin 10 polymorphisms on breast cancer susceptibility in Han women in Shaanxi Province.
    PLoS One. 2020;15:e0232174.
    >> Share

  134. HADGU E, Seifu D, Tigneh W, Bokretsion Y, et al
    Distribution and characteristics of androgen receptor (AR) in breast cancer among women in Addis Ababa, Ethiopia: A cross sectional study.
    PLoS One. 2020;15:e0232519.
    >> Share

  135. RINALDI J, Sokol ES, Hartmaier RJ, Trabucco SE, et al
    The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors.
    PLoS One. 2020;15:e0231999.
    >> Share

  136. LEE KN, Torres MA, Troeschel AN, He J, et al
    Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
    PLoS One. 2020;15:e0232581.
    >> Share

  137. LI X, Shen X, Zhou Y, Wang X, et al
    Classification of breast cancer histopathological images using interleaved DenseNet with SENet (IDSNet).
    PLoS One. 2020;15:e0232127.
    >> Share

  138. CHEN VC, Lin KY, Tsai YH, Weng JC, et al
    Connectome analysis of brain functional network alterations in breast cancer survivors with and without chemotherapy.
    PLoS One. 2020;15:e0232548.
    >> Share

  139. GARCIA-VAZQUEZ V, Calvo FA, Ledesma-Carbayo MJ, Sole CV, et al
    Intraoperative computed tomography imaging for dose calculation in intraoperative electron radiation therapy: Initial clinical observations.
    PLoS One. 2020;15:e0227155.
    >> Share

  140. AHN S, Chung YR, Seo AN, Kim M, et al
    Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer.
    PLoS One. 2020;15:e0233037.
    >> Share

  141. LINDENBERG M, van Beek A, Retel V, van Duijnhoven F, et al
    Early budget impact analysis on magnetic seed localization for non-palpable breast cancer surgery.
    PLoS One. 2020;15:e0232690.
    >> Share

  142. ANDERSON O, Guttilla Reed IK
    Regulation of cell growth and migration by miR-96 and miR-183 in a breast cancer model of epithelial-mesenchymal transition.
    PLoS One. 2020;15:e0233187.
    >> Share

  143. STUEBER TN, Diessner J, Bartmann C, Leinert E, et al
    Effect of adjuvant radiotherapy in elderly patients with breast cancer.
    PLoS One. 2020;15:e0229518.
    >> Share

  144. DING Y, Ding K, Yang H, He X, et al
    Does dose-dense neoadjuvant chemotherapy have clinically significant prognostic value in breast cancer?: A meta-analysis of 3,724 patients.
    PLoS One. 2020;15:e0234058.
    >> Share

  145. YEERKEN D, Hong R, Wang Y, Gong Y, et al
    PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancer.
    PLoS One. 2020;15:e0233750.
    >> Share

  146. OMASANGGAR R, Yu CY, Ang GY, Emran NA, et al
    Mitochondrial DNA mutations in Malaysian female breast cancer patients.
    PLoS One. 2020;15:e0233461.
    >> Share

  147. CHENG Y, Huang Z, Liao Q, Yu X, et al
    Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
    PLoS One. 2020;15:e0232800.
    >> Share

  148. ZHENG J, Wu J, Wang C, Zhuang S, et al
    Combination cyclin-dependent kinase 4/6 inhibitors and endocrine therapy versus endocrine monotherapy for hormonal receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0233571.
    >> Share

  149. RASMUSSEN GHF, Kristiansen M, Arroyo-Morales M, Voigt M, et al
    Absolute and relative reliability of pain sensitivity and functional outcomes of the affected shoulder among women with pain after breast cancer treatment.
    PLoS One. 2020;15:e0234118.
    >> Share

  150. WONG KK, Hussain FA
    TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets.
    PLoS One. 2020;15:e0233884.
    >> Share

  151. TRILLA-FUERTES L, Gamez-Pozo A, Arevalillo JM, Lopez-Vacas R, et al
    Bayesian networks established functional differences between breast cancer subtypes.
    PLoS One. 2020;15:e0234752.
    >> Share

  152. DISCALA M, Najor MS, Yung T, Morgan D, et al
    Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells.
    PLoS One. 2020;15:e0234146.
    >> Share

  153. LABROSSE J, Osdoit M, Hamy AS, Coussy F, et al
    Adjuvant chemotherapy for breast cancer after preoperative chemotherapy: A propensity score matched analysis.
    PLoS One. 2020;15:e0234173.
    >> Share

  154. MOON HR, Ospina-Munoz N, Noe-Kim V, Yang Y, et al
    Subtype-specific characterization of breast cancer invasion using a microfluidic tumor platform.
    PLoS One. 2020;15:e0234012.
    >> Share

  155. BUSS LA, Ang AD, Hock B, Robinson BA, et al
    Effect of post-implant exercise on tumour growth rate, perfusion and hypoxia in mice.
    PLoS One. 2020;15:e0229290.
    >> Share

  156. LEE C, Han M, Baek J
    Human observer performance on in-plane digital breast tomosynthesis images: Effects of reconstruction filters and data acquisition angles on signal detection.
    PLoS One. 2020;15:e0229915.
    >> Share

  157. DEMIRCIOGLU A, Grueneisen J, Ingenwerth M, Hoffmann O, et al
    A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer.
    PLoS One. 2020;15:e0234871.
    >> Share

  158. RAISNER R, Bainer R, Haverty PM, Benedetti KL, et al
    Super-enhancer acquisition drives oncogene expression in triple negative breast cancer.
    PLoS One. 2020;15:e0235343.
    >> Share

  159. OKUMA H, Sudah M, Kettunen T, Niukkanen A, et al
    Peritumor to tumor apparent diffusion coefficient ratio is associated with biologically more aggressive breast cancer features and correlates with the prognostication tools.
    PLoS One. 2020;15:e0235278.
    >> Share

  160. BURGUIN A, Furrer D, Ouellette G, Jacob S, et al
    Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines.
    PLoS One. 2020;15:e0234991.
    >> Share

  161. HAMY AS, Darrigues L, Laas E, De Croze D, et al
    Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy.
    PLoS One. 2020;15:e0234191.
    >> Share

  162. Retraction: Macrophage Colony-Stimulating Factor Augments Tie2-Expressing Monocyte Differentiation, Angiogenic Function, and Recruitment in a Mouse Model of Breast Cancer.
    PLoS One. 2020;15:e0235096.
    >> Share

  163. NEWTON A, Predina J, Mison M, Runge J, et al
    Intraoperative near-infrared imaging can identify canine mammary tumors, a spontaneously occurring, large animal model of human breast cancer.
    PLoS One. 2020;15:e0234791.
    >> Share

  164. THIJSSEN B, Wessels LFA
    Approximating multivariate posterior distribution functions from Monte Carlo samples for sequential Bayesian inference.
    PLoS One. 2020;15:e0230101.
    >> Share

  165. ARCHER S, Babb de Villiers C, Scheibl F, Carver T, et al
    Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study.
    PLoS One. 2020;15:e0229999.
    >> Share

  166. TANAKA M, Hsuan C, Oeki M, Shen W, et al
    Identification of characteristic compounds of moderate volatility in breast cancer cell lines.
    PLoS One. 2020;15:e0235442.
    >> Share

  167. THURING J, Kuhl CK, Barabasch A, Hitpass L, et al
    Signal changes in T2-weighted MRI of liver metastases under bevacizumab-A practical imaging biomarker?
    PLoS One. 2020;15:e0230553.
    >> Share

  168. RAINES MILENKOV A, Felini M, Baker E, Acharya R, et al
    Uptake of cancer screenings among a multiethnic refugee population in North Texas, 2014-2018.
    PLoS One. 2020;15:e0230675.
    >> Share

  169. HAILU HE, Mondul AM, Rozek LS, Geleta T, et al
    Descriptive Epidemiology of breast and gynecological cancers among patients attending Saint Paul's Hospital Millennium Medical College, Ethiopia.
    PLoS One. 2020;15:e0230625.
    >> Share

  170. DE KRUIF AJ, Chrifou R, Langeslag GL, Sondaal AEC, et al
    Perceptions of non-Western immigrant women on having breast cancer and their experiences with treatment-related changes in body weight and lifestyle: A qualitative study.
    PLoS One. 2020;15:e0235662.
    >> Share

  171. ULYTE A, Wei W, Dressel H, Gruebner O, et al
    Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines.
    PLoS One. 2020;15:e0231409.
    >> Share

  172. MAYORAL-VARO V, Calcabrini A, Sanchez-Bailon MP, Martinez-Costa OH, et al
    c-Src functionality controls self-renewal and glucose metabolism in MCF7 breast cancer stem cells.
    PLoS One. 2020;15:e0235850.
    >> Share

  173. NOZAKI Y, Motomura H, Tamori S, Kimura Y, et al
    High PKClambda expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patients.
    PLoS One. 2020;15:e0235747.
    >> Share

  174. HIENSCH AE, Peeters PHM, Jansen M, van der Wall E, et al
    Socio-ecological correlates of physical activity in breast and colon cancer survivors 4 years after participation in a randomized controlled exercise trial (PACT study).
    PLoS One. 2020;15:e0231663.
    >> Share

  175. WALSH CA, Akrap N, Garre E, Magnusson Y, et al
    The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer.
    PLoS One. 2020;15:e0236187.
    >> Share

  176. SHAHZAD N, Munir T, Javed M, Tasneem F, et al
    SHISA3, an antagonist of the Wnt/beta-catenin signaling, is epigenetically silenced and its ectopic expression suppresses growth in breast cancer.
    PLoS One. 2020;15:e0236192.
    >> Share

  177. BARE DJ, Cherny VV, DeCoursey TE, Abukhdeir AM, et al
    Expression and function of voltage gated proton channels (Hv1) in MDA-MB-231 cells.
    PLoS One. 2020;15:e0227522.
    >> Share

  178. AKIN E, Pelen NN, Tiryaki IU, Yalcin F, et al
    Parameter identification for gompertz and logistic dynamic equations.
    PLoS One. 2020;15:e0230582.
    >> Share

  179. GASILINA A, Premnauth G, Gurjar P, Biesiada J, et al
    IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer models.
    PLoS One. 2020;15:e0229801.
    >> Share

  180. YOO JJ, Lim YS, Kim MS, Lee B, et al
    Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer.
    PLoS One. 2020;15:e0236506.
    >> Share

  181. QUIAOIT K, DiCenzo D, Fatima K, Bhardwaj D, et al
    Quantitative ultrasound radiomics for therapy response monitoring in patients with locally advanced breast cancer: Multi-institutional study results.
    PLoS One. 2020;15:e0236182.
    >> Share

    In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors.
    PLoS One. 2020;15:e0232284.
    >> Share

  183. BADRAN A, Tul-Wahab A, Zafar H, Mohammad N, et al
    Antipsychotics drug aripiprazole as a lead against breast cancer cell line (MCF-7) in vitro.
    PLoS One. 2020;15:e0235676.
    >> Share

  184. ARIK A, Dodd E, Streftaris G
    Cancer morbidity trends and regional differences in England-A Bayesian analysis.
    PLoS One. 2020;15:e0232844.
    >> Share

  185. WIELEMA M, Dorrius MD, Pijnappel RM, De Bock GH, et al
    Diagnostic performance of breast tumor tissue selection in diffusion weighted imaging: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0232856.
    >> Share

  186. DRUCKER A, Teh EM, Kostyleva R, Rayson D, et al
    Comparative performance of different methods for circulating tumor cell enrichment in metastatic breast cancer patients.
    PLoS One. 2020;15:e0237308.
    >> Share

  187. VIJAYASARVESWARI V, Andrew AM, Jusoh M, Sabapathy T, et al
    Multi-stage feature selection (MSFS) algorithm for UWB-based early breast cancer size prediction.
    PLoS One. 2020;15:e0229367.
    >> Share

  188. ELSHARKAWY M, Vestring T, Raatschen HJ
    A ten-year, single-center experience: Concordance between breast core needle biopsy/vacuum-assisted biopsy and postoperative histopathology in B3 and B5a cases.
    PLoS One. 2020;15:e0233574.
    >> Share

  189. WAWRZYNIAK D, Grabowska M, Glodowicz P, Kuczynski K, et al
    Down-regulation of tenascin-C inhibits breast cancer cells development by cell growth, migration, and adhesion impairment.
    PLoS One. 2020;15:e0237889.
    >> Share

  190. AMINA M, Al Musayeib NM, Alarfaj NA, El-Tohamy MF, et al
    Biogenic green synthesis of MgO nanoparticles using Saussurea costus biomasses for a comprehensive detection of their antimicrobial, cytotoxicity against MCF-7 breast cancer cells and photocatalysis potentials.
    PLoS One. 2020;15:e0237567.
    >> Share

  191. PEPLONSKA B, Janasik B, McCormack V, Bukowska-Damska A, et al
    Cadmium and volumetric mammographic density: A cross-sectional study in Polish women.
    PLoS One. 2020;15:e0233369.
    >> Share

  192. JANK P, Gehlhaar C, Bianca L, Caterina F, et al
    MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.
    PLoS One. 2020;15:e0238021.
    >> Share

  193. JO W
    Funding sources and breast cancer research frame.
    PLoS One. 2020;15:e0238026.
    >> Share

  194. DE-LA-CRUZ-KU G, Luyo M, Morante Z, Enriquez D, et al
    Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience.
    PLoS One. 2020;15:e0237811.
    >> Share

  195. HOU H, Lyu Y, Jiang J, Wang M, et al
    Peripheral blood transcriptome identifies high-risk benign and malignant breast lesions.
    PLoS One. 2020;15:e0233713.
    >> Share

  196. SANTOS-SANCHEZ V, Cordoba-Dona JA, Viciana F, Escolar-Pujolar A, et al
    Geographical variations in cancer mortality and social inequalities in southern Spain (Andalusia). 2002-2013.
    PLoS One. 2020;15:e0233397.
    >> Share

  197. PHILIPOVSKIY A, Dwivedi AK, Gamez R, McCallum R, et al
    Association between tumor mutation profile and clinical outcomes among Hispanic Latina women with triple-negative breast cancer.
    PLoS One. 2020;15:e0238262.
    >> Share

  198. FERRANTI M, Pinnarelli L, Rosa A, Pastorino R, et al
    Evaluation of the breast cancer care network within the Lazio Region (Central Italy).
    PLoS One. 2020;15:e0238562.
    >> Share

  199. BISHOP MR, Omeler-Fenaud SM, Huskey ALW, Merner ND, et al
    Gene panel screening for insight towards breast cancer susceptibility in different ethnicities.
    PLoS One. 2020;15:e0238295.
    >> Share

  200. CUTLER W, Kolter J, Chambliss C, O'Neill H, et al
    Long term absence of invasive breast cancer diagnosis in 2,402,672 pre and postmenopausal women: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0237925.
    >> Share

  201. PORTER W, Snowden E, Hahn F, Ferguson M, et al
    High accuracy gene expression profiling of sorted cell subpopulations from breast cancer PDX model tissue.
    PLoS One. 2020;15:e0238594.
    >> Share

  202. TANIGUCHI K, Takada S, Omori M, Igawa T, et al
    Triple-negative pleomorphic lobular carcinoma and expression of androgen receptor: Personal case series and review of the literature.
    PLoS One. 2020;15:e0235790.
    >> Share

  203. HONG S, Youk T, Lee SJ, Kim KM, et al
    Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study.
    PLoS One. 2020;15:e0234927.
    >> Share

  204. HARATI R, Hafezi S, Mabondzo A, Tlili A, et al
    Silencing miR-202-3p increases MMP-1 and promotes a brain invasive phenotype in metastatic breast cancer cells.
    PLoS One. 2020;15:e0239292.
    >> Share

  205. GUO A, Drake BF, Khan YM, Langabeer Ii JR, et al
    Time-series cardiovascular risk factors and receipt of screening for breast, cervical, and colon cancer: The Guideline Advantage.
    PLoS One. 2020;15:e0236836.
    >> Share

  206. ROSEN S, Brisson BK, Durham AC, Munroe CM, et al
    Intratumoral collagen signatures predict clinical outcomes in feline mammary carcinoma.
    PLoS One. 2020;15:e0236516.
    >> Share

  207. LELLUPITIYAGE DON SS, Robertson KL, Lin HH, Labriola C, et al
    Nobiletin affects circadian rhythms and oncogenic characteristics in a cell-dependent manner.
    PLoS One. 2020;15:e0236315.
    >> Share

  208. PORCIELLO G, Montagnese C, Crispo A, Grimaldi M, et al
    Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial.
    PLoS One. 2020;15:e0239803.
    >> Share

  209. Retraction: Role of Activated Rac1/Cdc42 in Mediating Endothelial Cell Proliferation and Tumor Angiogenesis in Breast Cancer.
    PLoS One. 2020;15:e0240575.
    >> Share

  210. Retraction: Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating NDRG2 expression in breast cancer cells.
    PLoS One. 2020;15:e0240574.
    >> Share

  211. SOLIMAN SSM, Alhamidi TB, Abdin S, Almehdi AM, et al
    Effective targeting of breast cancer cells (MCF7) via novel biogenic synthesis of gold nanoparticles using cancer-derived metabolites.
    PLoS One. 2020;15:e0240156.
    >> Share

  212. DELARMELINA E, Buzelin MA, Souza BS, Souto FM, et al
    High positivity values for bovine leukemia virus in human breast cancer cases from Minas Gerais, Brazil.
    PLoS One. 2020;15:e0239745.
    >> Share

  213. SONG JH, Eum DY, Park SY, Jin YH, et al
    Inhibitory effect of ginsenoside Rg3 on cancer stemness and mesenchymal transition in breast cancer via regulation of myeloid-derived suppressor cells.
    PLoS One. 2020;15:e0240533.
    >> Share

  214. RODRIGUEZ NM, Casanova F, Pages G, Claure L, et al
    Community-based participatory design of a community health worker breast cancer training intervention for South Florida Latinx farmworkers.
    PLoS One. 2020;15:e0240827.
    >> Share

  215. Correction: Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines.
    PLoS One. 2020;15:e0241089.
    >> Share

  216. MOSAYEBI A, Mojaradi B, Bonyadi Naeini A, Khodadad Hosseini SH, et al
    Modeling and comparing data mining algorithms for prediction of recurrence of breast cancer.
    PLoS One. 2020;15:e0237658.
    >> Share

  217. PARK SH, Jeong YM, Lee HY, Kim EY, et al
    Opportunistic use of chest CT for screening osteoporosis and predicting the risk of incidental fracture in breast cancer patients: A retrospective longitudinal study.
    PLoS One. 2020;15:e0240084.
    >> Share

  218. CHA YJ, Koo JS
    Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors.
    PLoS One. 2020;15:e0238466.
    >> Share

  219. SHARMA D, Cartar H, Law N, Giles A, et al
    Optimization of microbubble enhancement of hyperthermia for cancer therapy in an in vivo breast tumour model.
    PLoS One. 2020;15:e0237372.
    >> Share

  220. ZHANG C, Zhao J, Niu J, Li D, et al
    New convolutional neural network model for screening and diagnosis of mammograms.
    PLoS One. 2020;15:e0237674.
    >> Share

  221. YEASMEEN T, Kelaher M, Brotherton JML, Malloy MJ, et al
    Understanding the participation of breast screening among women born in predominantly Muslim countries living in Victoria, Australia from record-linkage data.
    PLoS One. 2020;15:e0237341.
    >> Share

  222. DAHMANI Z, Addou-Klouche L, Gizard F, Dahou S, et al
    Metformin partially reverses the inhibitory effect of co-culture with ER-/PR-/HER2+ breast cancer cells on biomarkers of monocyte antitumor activity.
    PLoS One. 2020;15:e0240982.
    >> Share

  223. LEE SB, Gwark SC, Kang CM, Sohn G, et al
    The effects of poloxamer and sodium alginate mixture (Guardix-SG(R)) on range of motion after axillary lymph node dissection: A single-center, prospective, randomized, double-blind pilot study.
    PLoS One. 2020;15:e0238284.
    >> Share

  224. BAIO G, Fabbi M, Cilli M, Rosa F, et al
    Manganese-enhanced MRI (MEMRI) in breast and prostate cancers: Preliminary results exploring the potential role of calcium receptors.
    PLoS One. 2020;15:e0224414.
    >> Share

  225. ESPANOL AJ, Salem A, Di Bari M, Cristofaro I, et al
    The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype.
    PLoS One. 2020;15:e0226450.
    >> Share

  226. BARTLETT JMS, Bayani J, Kornaga EN, Danaher P, et al
    Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training.
    PLoS One. 2020;15:e0238593.
    >> Share

  227. TRACY JK, Adetunji F, Al Kibria GM, Swanberg JE, et al
    Cancer-work management: Hourly and salaried wage women's experiences managing the cancer-work interface following new breast cancer diagnosis.
    PLoS One. 2020;15:e0241795.
    >> Share

  228. BODILY WR, Shirts BH, Walsh T, Gulsuner S, et al
    Effects of germline and somatic events in candidate BRCA-like genes on breast-tumor signatures.
    PLoS One. 2020;15:e0239197.
    >> Share

  229. LUO CY, Natividad RJ, Lalli ML, Asthagiri AR, et al
    Multivariate relationships among nucleus and Golgi properties during fibrillar migration are robust to and unchanged by epithelial-to-mesenchymal transition.
    PLoS One. 2020;15:e0239188.
    >> Share

  230. HUANG JS, Pan HB, Yang TL, Hung BH, et al
    Kinetic patterns of benign and malignant breast lesions on contrast enhanced digital mammogram.
    PLoS One. 2020;15:e0239271.
    >> Share

  231. CUI P, Chen Y, Waili N, Li Y, et al
    Associations of serum C-peptide and insulin-like growth factor binding proteins-3 with breast cancer deaths.
    PLoS One. 2020;15:e0242310.
    >> Share

  232. CRESPO J, Sun H, Wu J, Ding QQ, et al
    Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy.
    PLoS One. 2020;15:e0241775.
    >> Share

  233. BAJAJ R, Tripathi R, Sridhar TS, Korlimarla A, et al
    Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer.
    PLoS One. 2020;15:e0242190.
    >> Share

  234. MO W, Ding Y, Zhao S, Zou D, et al
    Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
    PLoS One. 2020;15:e0241924.
    >> Share

  235. LIN H, Wu Y, Liang G, Chen L, et al
    Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery.
    PLoS One. 2020;15:e0242155.
    >> Share

  236. CHANG TC, Matossian MD, Elliott S, Burks HE, et al
    Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor.
    PLoS One. 2020;15:e0226464.
    >> Share

  237. BERA A, Subramanian M, Karaian J, Eklund M, et al
    Functional role of vitronectin in breast cancer.
    PLoS One. 2020;15:e0242141.
    >> Share

  238. WANANDI SI, Limanto A, Yunita E, Syahrani RA, et al
    In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells.
    PLoS One. 2020;15:e0240020.
    >> Share

  239. YOSHIKAWA K, Ishida M, Yanai H, Tsuta K, et al
    Adipophilin expression is an independent marker for poor prognosis of patients with triple-negative breast cancer: An immunohistochemical study.
    PLoS One. 2020;15:e0242563.
    >> Share

  240. CHIANG ZC, Chiu YK, Lee CC, Hsu NS, et al
    Preparation and characterization of antibody-drug conjugates acting on HER2-positive cancer cells.
    PLoS One. 2020;15:e0239813.
    >> Share

  241. MATHEWS PM, Robinson SA, Gire A, Baer AN, et al
    Extraglandular ocular involvement and morbidity and mortality in primary Sjogren's Syndrome.
    PLoS One. 2020;15:e0239769.
    >> Share

  242. AFRIN K, Iquebal AS, Karimi M, Souris A, et al
    Directionally dependent multi-view clustering using copula model.
    PLoS One. 2020;15:e0238996.
    >> Share

  243. TESFAW A, Alebachew W, Tiruneh M
    Why women with breast cancer presented late to health care facility in North-west Ethiopia? A qualitative study.
    PLoS One. 2020;15:e0243551.
    >> Share

  244. CARTER KJ, Castro F, Morcos RN
    A method for evaluating breast cancer screening strategies using screen-preventable loss of life.
    PLoS One. 2020;15:e0243113.
    >> Share

  245. ZOU Y, Fineberg S, Pearlman A, Feinman RD, et al
    The effect of a ketogenic diet and synergy with rapamycin in a mouse model of breast cancer.
    PLoS One. 2020;15:e0233662.
    >> Share

  246. DE MEULENAERE V, Descamps B, De Wever O, Vanhove C, et al
    In vivo selection of the MDA-MB-231br/eGFP cancer cell line to obtain a clinically relevant rat model for triple negative breast cancer brain metastasis.
    PLoS One. 2020;15:e0243156.
    >> Share

  247. FADDA M, Chappuis PO, Katapodi MC, Pagani O, et al
    Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?
    PLoS One. 2020;15:e0240054.
    >> Share

  248. SHI Y, Gong W, Gong X, Wang P, et al
    Genome-wide DNA methylation analysis of breast cancer MCF-7 / Taxol cells with MeDIP-Seq.
    PLoS One. 2020;15:e0241515.
    >> Share

  249. MAO Y, Zhao Y, Zhang Y, Yang H, et al
    In-depth characterization and comparison of the N-glycosylated proteome of two-dimensional- and three-dimensional-cultured breast cancer cells and xenografted tumors.
    PLoS One. 2020;15:e0243789.
    >> Share

  250. NAGHIBI L, Yazdani M, Momtazi-Borojeni AA, Razazan A, et al
    Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer.
    PLoS One. 2020;15:e0243550.
    >> Share

  251. DE LA CRUZ-KU G, Chambergo-Michilot D, Torres-Roman JS, Rebaza P, et al
    Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer.
    PLoS One. 2020;15:e0243447.
    >> Share

  252. BAR-SELA G, Cohen I, Avisar A, Loven D, et al
    Circulating blood extracellular vesicles as a tool to assess endothelial injury and chemotherapy toxicity in adjuvant cancer patients.
    PLoS One. 2020;15:e0240994.
    >> Share

  253. MOODLEY J, Constant D, Mwaka AD, Scott SE, et al
    Mapping awareness of breast and cervical cancer risk factors, symptoms and lay beliefs in Uganda and South Africa.
    PLoS One. 2020;15:e0240788.
    >> Share

  254. MOGAKA JJO, Chimbari MJ
    The mediating effects of public genomic knowledge in precision medicine implementation: A structural equation model approach.
    PLoS One. 2020;15:e0240585.
    >> Share

  255. LI X, Plataniotis KN
    How much off-the-shelf knowledge is transferable from natural images to pathology images?
    PLoS One. 2020;15:e0240530.
    >> Share

  256. CIRIA-SUAREZ L, Jimenez-Fonseca P, Palacin-Lois M, Antonanzas-Basa M, et al
    Ascertaining breast cancer patient experiences through a journey map: A qualitative study protocol.
    PLoS One. 2020;15:e0244355.
    >> Share

  257. WANG L, Wang W, Zeng S, Zheng H, et al
    Construction and validation of a 6-gene nomogram discriminating lung metastasis risk of breast cancer patients.
    PLoS One. 2020;15:e0244693.
    >> Share

  258. ZABALLA O, Perez A, Gomez Inhiesto E, Acaiturri Ayesta T, et al
    Identifying common treatments from Electronic Health Records with missing information. An application to breast cancer.
    PLoS One. 2020;15:e0244004.
    >> Share

  259. MOODLEY J, Williams P, Gohla G, Major P, et al
    Variation in breast cancer grading in 1,636 resections assessed using control charts and in silico kappa.
    PLoS One. 2020;15:e0242656.
    >> Share

    Breast self-examination practice and associated factors among female healthcare workers in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0241961.
    >> Share

  261. WINNARD PT JR, Vesuna F, Muthukumar S, Raman V, et al
    Divergent organ-specific isogenic metastatic cell lines identified using multi-omics exhibit differential drug sensitivity.
    PLoS One. 2020;15:e0242384.
    >> Share

  262. DE LOS CAMPOS G, Pook T, Gonzalez-Reymundez A, Simianer H, et al
    ANOVA-HD: Analysis of variance when both input and output layers are high-dimensional.
    PLoS One. 2020;15:e0243251.
    >> Share

  263. OSAPOETRA LO, Chan W, Tran W, Kolios MC, et al
    Comparison of methods for texture analysis of QUS parametric images in the characterization of breast lesions.
    PLoS One. 2020;15:e0244965.
    >> Share

  264. TOYODA Y, Tabuchi T, Hama H, Morishima T, et al
    Trends in clinical stage distribution and screening detection of cancer in Osaka, Japan: Stomach, colorectum, lung, breast and cervix.
    PLoS One. 2020;15:e0244644.
    >> Share

    January 2019
  265. SCHUETZ JM, Grundy A, Lee DG, Lai AS, et al
    Genetic variants in genes related to inflammation, apoptosis and autophagy in breast cancer risk.
    PLoS One. 2019;14:e0209010.
    >> Share

  266. LIU M, Yang Y, Xie F, Guo J, et al
    Could axillary clearance be avoided in clinically node-negative breast cancer patients with positive nodes diagnosed by ultrasound guided biopsy in the post-ACOSOG Z0011 era?
    PLoS One. 2019;14:e0210437.
    >> Share

  267. LAI YL, Su YC, Kao CH, Liang JA, et al
    Increased risk of varicella-zoster virus infection in patients with breast cancer after adjuvant radiotherapy: A population-based cohort study.
    PLoS One. 2019;14:e0209365.
    >> Share

  268. SHARMA A, Bandyopadhayaya S, Chowdhury K, Sharma T, et al
    Metformin exhibited anticancer activity by lowering cellular cholesterol content in breast cancer cells.
    PLoS One. 2019;14:e0209435.
    >> Share

  269. BONSU AB, Ncama BP
    Recognizing and appraising symptoms of breast cancer as a reason for delayed presentation in Ghanaian women: A qualitative study.
    PLoS One. 2019;14:e0208773.
    >> Share

  270. WATANABE T, Yagata H, Saito M, Okada H, et al
    A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients.
    PLoS One. 2019;14:e0208118.
    >> Share

  271. MOUSAVI SA, Kasaeian A, Pourkasmaee M, Ghavamzadeh A, et al
    Assessing the prognostic factors, survival, and recurrence incidence of triple negative breast cancer patients, a single center study in Iran.
    PLoS One. 2019;14:e0208701.
    >> Share

  272. MORGAT C, Schollhammer R, Macgrogan G, Barthe N, et al
    Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples.
    PLoS One. 2019;14:e0210905.
    >> Share

  273. CHATSIPROIOS D, Schmidts-Winkler IM, Konig L, Masur C, et al
    Topical treatment of vaginal dryness with a non-hormonal cream in women undergoing breast cancer treatment - An open prospective multicenter study.
    PLoS One. 2019;14:e0210967.
    >> Share

  274. VAN MAAREN MC, Kneepkens RF, Verbaan J, Huijgens PC, et al
    A conditional model predicting the 10-year annual extra mortality risk compared to the general population: a large population-based study in Dutch breast cancer patients.
    PLoS One. 2019;14:e0210887.
    >> Share

  275. LAAS E, Hamy AS, Michel AS, Panchbhaya N, et al
    Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach.
    PLoS One. 2019;14:e0208807.
    >> Share

  276. SHOWALTER LE, Oechsle C, Ghimirey N, Steele C, et al
    Th1 cytokines sensitize HER-expressing breast cancer cells to lapatinib.
    PLoS One. 2019;14:e0210209.
    >> Share

  277. Retraction: Plumbagin Suppresses the Invasion of HER2-Overexpressing Breast Cancer Cells through Inhibition of IKKalpha-Mediated NF-kappaB Activation.
    PLoS One. 2019;14:e0207273.
    >> Share

  278. KECHAVARZI BD, Wu H, Doman TN
    Bottom-up, integrated -omics analysis identifies broadly dosage-sensitive genes in breast cancer samples from TCGA.
    PLoS One. 2019;14:e0210910.
    >> Share

  279. CHITAPANARUX I, Nobnop W, Tippanya D, Sripan P, et al
    Clinical outcomes and dosimetric study of hypofractionated Helical TomoTherapy in breast cancer patients.
    PLoS One. 2019;14:e0211578.
    >> Share

  280. PIETERS HC, Green E, Khakshooy S, Sleven M, et al
    A qualitative comparison of how older breast cancer survivors process treatment information regarding endocrine therapy.
    PLoS One. 2019;14:e0210972.
    >> Share

  281. MICHEL LL, Sommer L, Gonzalez Silos R, Lorenzo Bermejo J, et al
    Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index.
    PLoS One. 2019;14:e0211337.
    >> Share

  282. Expression of Concern: Ramentaceone, a Naphthoquinone Derived from Drosera sp., Induces Apoptosis by Suppressing PI3K/Akt Signaling in Breast Cancer Cells.
    PLoS One. 2019;14:e0211655.
    >> Share

  283. WILLIAMS LA, Casbas-Hernandez P, Nichols HB, Tse CK, et al
    Risk factors for Luminal A ductal carcinoma in situ (DCIS) and invasive breast cancer in the Carolina Breast Cancer Study.
    PLoS One. 2019;14:e0211488.
    >> Share

  284. HEBERT-MAGEE S, Yu H, Behring M, Jadhav T, et al
    The combined survival effect of codon 72 polymorphisms and p53 somatic mutations in breast cancer depends on race and molecular subtype.
    PLoS One. 2019;14:e0211734.
    >> Share

  285. LYNG FM, Traynor D, Nguyen TNQ, Meade AD, et al
    Discrimination of breast cancer from benign tumours using Raman spectroscopy.
    PLoS One. 2019;14:e0212376.
    >> Share

  286. COLLIN LJ, McCullough LE, Conway K, White AJ, et al
    Reproductive characteristics modify the association between global DNA methylation and breast cancer risk in a population-based sample of women.
    PLoS One. 2019;14:e0210884.
    >> Share

  287. PEARLMAN A, Rahman MT, Upadhyay K, Loke J, et al
    Ectopic Otoconin 90 expression in triple negative breast cancer cell lines is associated with metastasis functions.
    PLoS One. 2019;14:e0211737.
    >> Share

  288. MURPHY C, Muscat A, Ashley D, Mukaro V, et al
    Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial-Clinical outcomes and molecular determinants of response.
    PLoS One. 2019;14:e0210891.
    >> Share

  289. MEYER SB, Foley K, Olver I, Ward PR, et al
    Alcohol and breast cancer risk: Middle-aged women's logic and recommendations for reducing consumption in Australia.
    PLoS One. 2019;14:e0211293.
    >> Share

  290. JIANG X, Wells A, Brufsky A, Neapolitan R, et al
    A clinical decision support system learned from data to personalize treatment recommendations towards preventing breast cancer metastasis.
    PLoS One. 2019;14:e0213292.
    >> Share

  291. OW SGW, Ong PY, Lee SC
    Discoveries beyond BRCA1/2: Multigene testing in an Asian multi-ethnic cohort suspected of hereditary breast cancer syndrome in the real world.
    PLoS One. 2019;14:e0213746.
    >> Share

  292. ROEHRER S, Stork V, Ludwig C, Minceva M, et al
    Analyzing bioactive effects of the minor hop compound xanthohumol C on human breast cancer cells using quantitative proteomics.
    PLoS One. 2019;14:e0213469.
    >> Share

  293. PIOTRZKOWSKA-WROBLEWSKA H, Dobruch-Sobczak K, Klimonda Z, Karwat P, et al
    Monitoring breast cancer response to neoadjuvant chemotherapy with ultrasound signal statistics and integrated backscatter.
    PLoS One. 2019;14:e0213749.
    >> Share

  294. EGELAND NG, Austdal M, van Diermen-Hidle B, Rewcastle E, et al
    Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients.
    PLoS One. 2019;14:e0212527.
    >> Share

  295. DUCRET A, James I, Wilson S, Feilke M, et al
    Translation and evaluation of a pre-clinical 5-protein response prediction signature in a breast cancer phase Ib clinical trial.
    PLoS One. 2019;14:e0213892.
    >> Share

  296. WANG H, Xu C, Kong X, Li X, et al
    Correction: Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer.
    PLoS One. 2019;14:e0214433.
    >> Share

  297. BONSU AB, Ncama BP
    Integration of breast cancer prevention and early detection into cancer palliative care model.
    PLoS One. 2019;14:e0212806.
    >> Share

  298. VENTURA-ALFARO CE, Avila-Burgos L, Torres-Mejia G
    Adherence of Mexican physicians to clinical guidelines in the management of breast cancer: Effect of the National Catastrophic Health Expenditure Fund.
    PLoS One. 2019;14:e0212841.
    >> Share

  299. HOLMSTROM O, Linder N, Moilanen H, Suutala A, et al
    Detection of breast cancer lymph node metastases in frozen sections with a point-of-care low-cost microscope scanner.
    PLoS One. 2019;14:e0208366.
    >> Share

  300. JIANG Y, Chen L, Zhang H, Xiao X, et al
    Breast cancer histopathological image classification using convolutional neural networks with small SE-ResNet module.
    PLoS One. 2019;14:e0214587.
    >> Share

  301. WITTKOWSKI KM, Dadurian C, Seybold MP, Kim HS, et al
    Correction: Complex polymorphisms in endocytosis genes suggest alpha-cyclodextrin as a treatment for breast cancer.
    PLoS One. 2019;14:e0214826.
    >> Share

  302. ZITO P, Labbozzetta M, Notarbartolo M, Sajeva M, et al
    Essential oil of Cyphostemma juttae (Vitaceae): Chemical composition and antitumor mechanism in triple negative breast cancer cells.
    PLoS One. 2019;14:e0214594.
    >> Share

  303. ZHANG Y, Chen J, Wang Y, Wang D, et al
    Multilayer network analysis of miRNA and protein expression profiles in breast cancer patients.
    PLoS One. 2019;14:e0202311.
    >> Share

  304. BAATJES KJ, Kotze MJ, McCaul M, Conradie M, et al
    Baseline bone health status in multi-ethnic South African postmenopausal breast cancer patients at initiation of aromatase inhibitor therapy: A descriptive study.
    PLoS One. 2019;14:e0214153.
    >> Share

  305. SIDDIQUE AB, Ebrahim H, Mohyeldin M, Qusa M, et al
    Novel liquid-liquid extraction and self-emulsion methods for simplified isolation of extra-virgin olive oil phenolics with emphasis on (-)-oleocanthal and its oral anti-breast cancer activity.
    PLoS One. 2019;14:e0214798.
    >> Share

  306. BURTON LJ, Hawsawi O, Sweeney J, Bowen N, et al
    CCAAT-displacement protein/cut homeobox transcription factor (CUX1) represses estrogen receptor-alpha (ER-alpha) in triple-negative breast cancer cells and can be antagonized by muscadine grape skin extract (MSKE).
    PLoS One. 2019;14:e0214844.
    >> Share

  307. FURUYA Y
    Early neutropenia on day 8 treated with adjuvant Docetaxel-based chemotherapy in early breast cancer patients: Putative mechanisms within the neutrophil pool system.
    PLoS One. 2019;14:e0215576.
    >> Share

  308. PARE R, Soon PS, Shah A, Lee CS, et al
    Differential expression of senescence tumour markers and its implications on survival outcomes of breast cancer patients.
    PLoS One. 2019;14:e0214604.
    >> Share

  309. LYNG FM, Traynor D, Nguyen TNQ, Meade AD, et al
    Correction: Discrimination of breast cancer from benign tumours using Raman spectroscopy.
    PLoS One. 2019;14:e0216311.
    >> Share

  310. WEN WX, Leong CO
    Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer.
    PLoS One. 2019;14:e0215381.
    >> Share

  311. LOI S, Michiels S, Baselga J, Bartlett JMS, et al
    Correction: PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer.
    PLoS One. 2019;14:e0216175.
    >> Share

  312. NOYAN S, Gurdal H, Gur Dedeoglu B
    Involvement of miR-770-5p in trastuzumab response in HER2 positive breast cancer cells.
    PLoS One. 2019;14:e0215894.
    >> Share

  313. ADLER G, Kaufman G, Simon-Tuval T
    Healthcare utilization of breast cancer patients following telephone-based consultations of oncology nurse navigator via telemedical care.
    PLoS One. 2019;14:e0216365.
    >> Share

  314. TVEITARAS MK, Selheim F, Sortland K, Reed RK, et al
    Protein expression profiling of plasma and lungs at different stages of metastatic development in a human triple negative breast cancer xenograft model.
    PLoS One. 2019;14:e0215909.
    >> Share

  315. LEI K, He X, Yu L, Ni C, et al
    Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer.
    PLoS One. 2019;14:e0215948.
    >> Share

  316. SALGUERO-ARANDA C, Sancho-Mensat D, Canals-Lorente B, Sultan S, et al
    STAT6 knockdown using multiple siRNA sequences inhibits proliferation and induces apoptosis of human colorectal and breast cancer cell lines.
    PLoS One. 2019;14:e0207558.
    >> Share

  317. DIETEL E, Brobeil A, Delventhal L, Tag C, et al
    Crosstalks of the PTPIP51 interactome revealed in Her2 amplified breast cancer cells by the novel small molecule LDC3/Dynarrestin.
    PLoS One. 2019;14:e0216642.
    >> Share

  318. WITLOX L, Velthuis MJ, Boer JH, Steins Bisschop CN, et al
    Attendance and compliance with an exercise program during localized breast cancer treatment in a randomized controlled trial: The PACT study.
    PLoS One. 2019;14:e0215517.
    >> Share

  319. UHR K, Prager-van der Smissen WJC, Heine AAJ, Ozturk B, et al
    MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines.
    PLoS One. 2019;14:e0216400.
    >> Share

  320. ZHAO Q, Howard EW, Parris AB, Ma Z, et al
    Bisphenol AF promotes estrogen receptor-positive breast cancer cell proliferation through amphiregulin-mediated crosstalk with receptor tyrosine kinase signaling.
    PLoS One. 2019;14:e0216469.
    >> Share

  321. KIM N, Chung W, Eum HH, Lee HO, et al
    Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer.
    PLoS One. 2019;14:e0217196.
    >> Share

  322. ARNOLD M, Pfeifer K, Quante AS
    Is risk-stratified breast cancer screening economically efficient in Germany?
    PLoS One. 2019;14:e0217213.
    >> Share

  323. MONSALVE-LANCHEROS A, Ibanez-Pinilla M, Ramirez-Clavijo S
    Detection of mammagloblin by RT-PCR as a biomarker for lymph node metastasis in breast cancer patients: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0216989.
    >> Share

  324. ZHANG X, Zhang B, Zhang P, Lian L, et al
    Norcantharidin regulates ERalpha signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells.
    PLoS One. 2019;14:e0217181.
    >> Share

  325. LANDRY AP, Zador Z, Haq R, Cusimano MD, et al
    Reclassification of breast cancer: Towards improved diagnosis and outcome.
    PLoS One. 2019;14:e0217036.
    >> Share

  326. KUROZUMI S, Yamaguchi Y, Matsumoto H, Kurosumi M, et al
    Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausal ER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy.
    PLoS One. 2019;14:e0217279.
    >> Share

  327. SALES-DIAS J, Silva G, Lamy M, Ferreira A, et al
    The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells.
    PLoS One. 2019;14:e0217002.
    >> Share

  328. SALEH ME, Gadalla R, Hassan H, Afifi A, et al
    The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4+ T cell polarization in inflammatory and non-inflammatory breast cancer patients.
    PLoS One. 2019;14:e0217550.
    >> Share

  329. RATH M, Li Q, Li H, Lindstrom S, et al
    Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients.
    PLoS One. 2019;14:e0216997.
    >> Share

  330. HAJJAR A, Ergun MA, Alagoz O, Rampurwala M, et al
    Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer.
    PLoS One. 2019;14:e0217778.
    >> Share

  331. Expression of Concern: Microenvironment Promotes Tumor Cell Reprogramming in Human Breast Cancer Cell Lines.
    PLoS One. 2019;14:e0217961.
    >> Share

  332. FULTANG N, Illendula A, Chen B, Wu C, et al
    Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ss activity.
    PLoS One. 2019;14:e0217789.
    >> Share

  333. ESPLUGAS R, Arenas M, Serra N, Belles M, et al
    Effect of radiotherapy on the expression of cardiovascular disease-related miRNA-146a, -155, -221 and -222 in blood of women with breast cancer.
    PLoS One. 2019;14:e0217443.
    >> Share

  334. GIUDICI F, Petracci E, Nanni O, Bottin C, et al
    Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis.
    PLoS One. 2019;14:e0218030.
    >> Share

  335. SHARP JW, Hippe DS, Nakigudde G, Anderson BO, et al
    Modifiable patient-related barriers and their association with breast cancer detection practices among Ugandan women without a diagnosis of breast cancer.
    PLoS One. 2019;14:e0217938.
    >> Share

  336. JUNG SY, Mancuso N, Papp J, Sobel E, et al
    Post genome-wide gene-environment interaction study: The effect of genetically driven insulin resistance on breast cancer risk using Mendelian randomization.
    PLoS One. 2019;14:e0218917.
    >> Share

  337. WESSELS DJ, Pradhan N, Park YN, Klepitsch MA, et al
    Reciprocal signaling and direct physical interactions between fibroblasts and breast cancer cells in a 3D environment.
    PLoS One. 2019;14:e0218854.
    >> Share

  338. EKDAHL HJELM T, Matovu A, Mugisha N, Lofgren J, et al
    Breast cancer care in Uganda: A multicenter study on the frequency of breast cancer surgery in relation to the incidence of breast cancer.
    PLoS One. 2019;14:e0219601.
    >> Share

  339. Retraction: Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.
    PLoS One. 2019;14:e0219887.
    >> Share

  340. STUR E, Aristizabal-Pachon AF, Peronni KC, Agostini LP, et al
    Glyphosate-based herbicides at low doses affect canonical pathways in estrogen positive and negative breast cancer cell lines.
    PLoS One. 2019;14:e0219610.
    >> Share

  341. IMRAN M, Al-Wassia R, Alkhayyat SS, Baig M, et al
    Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: A tertiary care center survey in the western region of Saudi Arabia.
    PLoS One. 2019;14:e0219093.
    >> Share

  342. HEQUET D, Huchon C, Soilly AL, Asselain B, et al
    Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study.
    PLoS One. 2019;14:e0210917.
    >> Share

  343. HERR D, Wischnewsky M, Joukhadar R, Chow O, et al
    Does chemotherapy improve survival in patients with nodal positive luminal A breast cancer? A retrospective Multicenter Study.
    PLoS One. 2019;14:e0218434.
    >> Share

  344. TERAVA J, Tiainen L, Lamminmaki U, Kellokumpu-Lehtinen PL, et al
    Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma.
    PLoS One. 2019;14:e0219480.
    >> Share

  345. GEBREMARIAM A, Addissie A, Worku A, Assefa M, et al
    Perspectives of patients, family members, and health care providers on late diagnosis of breast cancer in Ethiopia: A qualitative study.
    PLoS One. 2019;14:e0220769.
    >> Share

  346. SARKAR A, Chanda A, Regmi SC, Karve K, et al
    Recombinant human PRG4 (rhPRG4) suppresses breast cancer cell invasion by inhibiting TGFbeta-Hyaluronan-CD44 signalling pathway.
    PLoS One. 2019;14:e0219697.
    >> Share

  347. Expression of Concern: Hydrazinocurcumin Encapsuled Nanoparticles "Re-Educate" Tumor-Associated Macrophages and Exhibit Anti-Tumor Effects on Breast Cancer Following STAT3 Suppression.
    PLoS One. 2019;14:e0220672.
    >> Share

  348. DI COSIMO S, La Verde N, Moretti A, Cazzaniga ME, et al
    Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study.
    PLoS One. 2019;14:e0220644.
    >> Share

  349. POULADI N, Abdolahi S, Farajzadeh D, Hosseinpour Feizi MA, et al
    Haplotype and linkage disequilibrium of TP53-WRAP53 locus in Iranian-Azeri women with breast cancer.
    PLoS One. 2019;14:e0220727.
    >> Share

  350. WANG L, Xiao Y, Ping Y, Li J, et al
    Correction: Integrating Multi-Omics for Uncovering the Architecture of Cross-Talking Pathways in Breast Cancer.
    PLoS One. 2019;14:e0221483.
    >> Share

  351. BADGUJAR NV, Tarapara BV, Shah FD
    Computational analysis of high-risk SNPs in human CHK2 gene responsible for hereditary breast cancer: A functional and structural impact.
    PLoS One. 2019;14:e0220711.
    >> Share

  352. AMIRFALLAH A, Arason A, Einarsson H, Gudmundsdottir ET, et al
    High expression of the vacuole membrane protein 1 (VMP1) is a potential marker of poor prognosis in HER2 positive breast cancer.
    PLoS One. 2019;14:e0221413.
    >> Share

  353. CLEMENT-ZHAO A, Tanguy ML, Cottu P, De La Lande B, et al
    Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation.
    PLoS One. 2019;14:e0221816.
    >> Share

  354. TIAN W, Yao Y, Fan G, Zhou Y, et al
    Changes in lipid profiles during and after (neo)adjuvant chemotherapy in women with early-stage breast cancer: A retrospective study.
    PLoS One. 2019;14:e0221866.
    >> Share

  355. YOON CI, Ahn SG, Bae SJ, Shin YJ, et al
    High A20 expression negatively impacts survival in patients with breast cancer.
    PLoS One. 2019;14:e0221721.
    >> Share

  356. SCHAFFAR R, Bouchardy C, Chappuis PO, Bodmer A, et al
    A population-based cohort of young women diagnosed with breast cancer in Geneva, Switzerland.
    PLoS One. 2019;14:e0222136.
    >> Share

  357. ABDEL-FATTAH M, Saeed H, El-Shennawy L, Shalaby M, et al
    The Arabian camel, Camelus dromedarius interferon epsilon: Functional expression, in vitro refolding, purification and cytotoxicity on breast cancer cell lines.
    PLoS One. 2019;14:e0213880.
    >> Share

  358. LU Y, Zhang L, Zhang Q, Zhang Y, et al
    The association of D-dimer with clinicopathological features of breast cancer and its usefulness in differential diagnosis: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0221374.
    >> Share

  359. SATOMI-TSUSHITA N, Shimomura A, Matsuzaki J, Yamamoto Y, et al
    Serum microRNA-based prediction of responsiveness to eribulin in metastatic breast cancer.
    PLoS One. 2019;14:e0222024.
    >> Share

  360. BROUWER A, De Laere B, van Dam PJ, Peeters D, et al
    HER-2 status of circulating tumor cells in a metastatic breast cancer cohort: A comparative study on characterization techniques.
    PLoS One. 2019;14:e0220906.
    >> Share

  361. ELBASHEER MMA, Alkhidir AGA, Mohammed SMA, Abbas AAH, et al
    Spatial distribution of breast cancer in Sudan 2010-2016.
    PLoS One. 2019;14:e0211085.
    >> Share

  362. HASSEN AM, Taye G, Gizaw M, Hussien FM, et al
    Quality of life and associated factors among patients with breast cancer under chemotherapy at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.
    PLoS One. 2019;14:e0222629.
    >> Share

  363. CHEN HH, Lin CH, Chen DY, Chao WC, et al
    Risk of major autoimmune diseases in female breast cancer patients: A nationwide, population-based cohort study.
    PLoS One. 2019;14:e0222860.
    >> Share

  364. MUNOZ R, Hileeto D, Cruz-Munoz W, Wood GA, et al
    Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion.
    PLoS One. 2019;14:e0222580.
    >> Share

  365. BAGEGNI NA, Tao Y, Ademuyiwa FO
    Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database.
    PLoS One. 2019;14:e0222358.
    >> Share

  366. FUNAKOSHI Y, Wang Y, Semba T, Masuda H, et al
    Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype.
    PLoS One. 2019;14:e0222336.
    >> Share

  367. JUNG KH, Lee EJ, Park JW, Lee JH, et al
    EGF receptor stimulation shifts breast cancer cell glucose metabolism toward glycolytic flux through PI3 kinase signaling.
    PLoS One. 2019;14:e0221294.
    >> Share

  368. LI Y, Giorgi EE, Beckman KB, Caberto C, et al
    Association between mitochondrial genetic variation and breast cancer risk: The Multiethnic Cohort.
    PLoS One. 2019;14:e0222284.
    >> Share

  369. HALASZ LM, Patel SA, McDougall JA, Fedorenko C, et al
    Intensity modulated radiation therapy following lumpectomy in early-stage breast cancer: Patterns of use and cost consequences among Medicare beneficiaries.
    PLoS One. 2019;14:e0222904.
    >> Share

  370. CHIGNOLA R, Sega M, Molesini B, Baruzzi A, et al
    Collective radioresistance of T47D breast carcinoma cells is mediated by a Syncytin-1 homologous protein.
    PLoS One. 2019;14:e0206713.
    >> Share

  371. WINSLOW S, Scholz A, Rappl P, Brauss TF, et al
    Macrophages attenuate the transcription of CYP1A1 in breast tumor cells and enhance their proliferation.
    PLoS One. 2019;14:e0209694.
    >> Share

  372. LEE KJ, Piett CG, Andrews JF, Mann E, et al
    Defective base excision repair in the response to DNA damaging agents in triple negative breast cancer.
    PLoS One. 2019;14:e0223725.
    >> Share

  373. ZHAI Q, Fan J, Lin Q, Liu X, et al
    Tumor stromal type is associated with stromal PD-L1 expression and predicts outcomes in breast cancer.
    PLoS One. 2019;14:e0223325.
    >> Share

  374. DE LEMOS LLP, Carvalho de Souza M, Pena Moreira D, Ribeiro Fernandes Almeida PH, et al
    Stage at diagnosis and stage-specific survival of breast cancer in Latin America and the Caribbean: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0224012.
    >> Share

  375. SANTOYO-OLSSON J, Stewart AL, Samayoa C, Palomino H, et al
    Translating a stress management intervention for rural Latina breast cancer survivors: The Nuevo Amanecer-II.
    PLoS One. 2019;14:e0224068.
    >> Share

  376. SATO J, Shimomura A, Kawauchi J, Matsuzaki J, et al
    Brain metastasis-related microRNAs in patients with advanced breast cancer.
    PLoS One. 2019;14:e0221538.
    >> Share

  377. HILL DA, Prossnitz ER, Royce M, Nibbe A, et al
    Temporal trends in breast cancer survival by race and ethnicity: A population-based cohort study.
    PLoS One. 2019;14:e0224064.
    >> Share

  378. COWPPLI-BONY A, Tretarre B, Marrer E, Defossez G, et al
    Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France.
    PLoS One. 2019;14:e0224275.
    >> Share

  379. CHENG W, Shen X, Xing M
    Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer.
    PLoS One. 2019;14:e0221093.
    >> Share

  380. KIM HJ, Park JY, Lee TS, Song IH, et al
    PET imaging of HER2 expression with an 18F-fluoride labeled aptamer.
    PLoS One. 2019;14:e0211047.
    >> Share

  381. OLIVIER M, Bouaoun L, Villar S, Robitaille A, et al
    Molecular features of premenopausal breast cancers in Latin American women: Pilot results from the PRECAMA study.
    PLoS One. 2019;14:e0210372.
    >> Share

  382. DELGADO R, Nunez-Gonzalez JD
    Enhancing Confusion Entropy (CEN) for binary and multiclass classification.
    PLoS One. 2019;14:e0210264.
    >> Share

  383. TAVAKOLI TABA S, Brennan PC, Lewis S
    Dynamics of breast imaging research: A global scoping review and Sino-Australian comparison case study.
    PLoS One. 2019;14:e0210256.
    >> Share

  384. HELLERHOFF K, Birnbacher L, Sztrokay-Gaul A, Grandl S, et al
    Assessment of intraductal carcinoma in situ (DCIS) using grating-based X-ray phase-contrast CT at conventional X-ray sources: An experimental ex-vivo study.
    PLoS One. 2019;14:e0210291.
    >> Share

  385. FOKIALAKIS N, Alexi X, Aligiannis N, Boulaka A, et al
    Biological evaluation of isoflavonoids from Genista halacsyi using estrogen-target cells: Activities of glucosides compared to aglycones.
    PLoS One. 2019;14:e0210247.
    >> Share

  386. MANDRIK O, Yaumenenka A, Herrero R, Jonker MF, et al
    Population preferences for breast cancer screening policies: Discrete choice experiment in Belarus.
    PLoS One. 2019;14:e0224667.
    >> Share

  387. MENDONCA P, Horton A, Bauer D, Messeha S, et al
    The inhibitory effects of butein on cell proliferation and TNF-alpha-induced CCL2 release in racially different triple negative breast cancer cells.
    PLoS One. 2019;14:e0215269.
    >> Share

  388. SHAHRIYARI L, Abdel-Rahman M, Cebulla C
    BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19.
    PLoS One. 2019;14:e0211507.
    >> Share

  389. HUANG YH, Lee MS, Lou YS, Lai HC, et al
    Propofol-based total intravenous anesthesia did not improve survival compared to desflurane anesthesia in breast cancer surgery.
    PLoS One. 2019;14:e0224728.
    >> Share

  390. CURRY JM, Besmer DM, Erick TK, Steuerwald N, et al
    Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice.
    PLoS One. 2019;14:e0224309.
    >> Share

  391. AFKHAMI M, Schmolze D, Yost SE, Frankel PH, et al
    Mutation and immune profiling of metaplastic breast cancer: Correlation with survival.
    PLoS One. 2019;14:e0224726.
    >> Share

  392. HEDAYATI E, Fracheboud L, Srikant V, Greber D, et al
    Economic benefits of subcutaneous trastuzumab administration: A single institutional study from Karolinska University Hospital in Sweden.
    PLoS One. 2019;14:e0211783.
    >> Share

  393. MINAMI Y, Kanemura S, Kawai M, Nishino Y, et al
    Alcohol consumption and survival after breast cancer diagnosis in Japanese women: A prospective patient cohort study.
    PLoS One. 2019;14:e0224797.
    >> Share

  394. MREMI A, Broadwater G, Jackson K, Amsi P, et al
    Breast cancer in Tanzanian, black American, and white American women: An assessment of prognostic and predictive features, including tumor infiltrating lymphocytes.
    PLoS One. 2019;14:e0224760.
    >> Share

  395. TERRAZZINO S, Cargnin S, Deantonio L, Pisani C, et al
    Impact of ATM rs1801516 on late skin reactions of radiotherapy for breast cancer: Evidences from a cohort study and a trial sequential meta-analysis.
    PLoS One. 2019;14:e0225685.
    >> Share

  396. GIORDANO A, Liu Y, Armeson K, Park Y, et al
    Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer.
    PLoS One. 2019;14:e0224420.
    >> Share

  397. SSENTONGO P, Lewcun JA, Candela X, Ssentongo AE, et al
    Regional, racial, gender, and tumor biology disparities in breast cancer survival rates in Africa: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0225039.
    >> Share

  398. REDMOND AM, Omarjee S, Chernukhin I, Le Romancer M, et al
    Analysis of HER2 genomic binding in breast cancer cells identifies a global role in direct gene regulation.
    PLoS One. 2019;14:e0225180.
    >> Share

  399. LJEPOJA B, Schreiber C, Gegenfurtner FA, Garcia-Roman J, et al
    Inducible microRNA-200c decreases motility of breast cancer cells and reduces filamin A.
    PLoS One. 2019;14:e0224314.
    >> Share

  400. CATTEAU X, Simon P, Jondet M, Vanhaeverbeek M, et al
    Quantification of stromal reaction in breast carcinoma and its correlation with tumor grade and free progression survival.
    PLoS One. 2019;14:e0210263.
    >> Share

  401. CHENG W, Shen X, Xing M
    Correction: Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer.
    PLoS One. 2019;14:e0225986.
    >> Share

  402. RUPJI M, Dwivedi B, Kowalski J
    NOJAH: NOt Just Another Heatmap for genome-wide cluster analysis.
    PLoS One. 2019;14:e0204542.
    >> Share

  403. FORGET P, Bouche G, Duhoux FP, Coulie PG, et al
    Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial.
    PLoS One. 2019;14:e0225748.
    >> Share

  404. TETEH D, Ericson M, Monice S, Dawkins-Moultin L, et al
    The Black identity, hair product use, and breast cancer scale.
    PLoS One. 2019;14:e0225305.
    >> Share

  405. PARK J, Shin Y, Kim TH, Kim DH, et al
    Plasma metabolites as possible biomarkers for diagnosis of breast cancer.
    PLoS One. 2019;14:e0225129.
    >> Share

  406. YOO B, Meka N, Sheedy P, Billig AM, et al
    MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancer.
    PLoS One. 2019;14:e0226356.
    >> Share

  407. Retraction: Ramentaceone, a Naphthoquinone Derived from Drosera sp., Induces Apoptosis by Suppressing PI3K/Akt Signaling in Breast Cancer Cells.
    PLoS One. 2019;14:e0226703.
    >> Share

  408. WEN W, Xuan D, Hu Y, Li X, et al
    Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography/computed tomography in patients with breast cancer: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0225959.
    >> Share

  409. JOGI A, Ehinger A, Hartman L, Alkner S, et al
    Expression of HIF-1alpha is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer.
    PLoS One. 2019;14:e0226150.
    >> Share

  410. PARK HS, Lee JD, Kim JY, Park S, et al
    Establishment of chemosensitivity tests in triple-negative and BRCA-mutated breast cancer patient-derived xenograft models.
    PLoS One. 2019;14:e0225082.
    >> Share

  411. ROMAN M, Sala M, Domingo L, Posso M, et al
    Personalized breast cancer screening strategies: A systematic review and quality assessment.
    PLoS One. 2019;14:e0226352.
    >> Share

  412. TALMONT F, Mouledous L, Baranger M, Gomez-Brouchet A, et al
    Development and characterization of sphingosine 1-phosphate receptor 1 monoclonal antibody suitable for cell imaging and biochemical studies of endogenous receptors.
    PLoS One. 2019;14:e0213203.
    >> Share

  413. STARK GF, Hart GR, Nartowt BJ, Deng J, et al
    Predicting breast cancer risk using personal health data and machine learning models.
    PLoS One. 2019;14:e0226765.
    >> Share

  414. GIUDICI F, Petracci E, Nanni O, Bottin C, et al
    Correction: Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis.
    PLoS One. 2019;14:e0227068.
    >> Share

  415. JIANG Y, Weinberg CR, Sandler DP, Zhao S, et al
    Use of detailed family history data to improve risk prediction,with application to breast cancer screening.
    PLoS One. 2019;14:e0226407.
    >> Share

  416. LEE SJ, Sim TS, Shin HY, Lee J, et al
    Microslit on a chip: A simplified filter to capture circulating tumor cells enlarged with microbeads.
    PLoS One. 2019;14:e0223193.
    >> Share

  417. SHETH M, Gerovitch A, Welsch R, Markuzon N, et al
    The Univariate Flagging Algorithm (UFA): An interpretable approach for predictive modeling.
    PLoS One. 2019;14:e0223161.
    >> Share

  418. HECK L, Dierolf M, Jud C, Eggl E, et al
    Contrast-enhanced spectral mammography with a compact synchrotron source.
    PLoS One. 2019;14:e0222816.
    >> Share

  419. WU WP, Wu HK, Chen CJ, Lee CW, et al
    Higher underestimation of tumour size post-neoadjuvant chemotherapy with breast magnetic resonance imaging (MRI)-A concordance comparison cohort analysis.
    PLoS One. 2019;14:e0222917.
    >> Share

  420. ABECASSIS J, Hamy AS, Laurent C, Sadacca B, et al
    Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data.
    PLoS One. 2019;14:e0224143.
    >> Share

  421. SHON EJ, Townsend AL
    Predictors of never having a mammogram among Chinese, Vietnamese, and Korean immigrant women in the U.S.
    PLoS One. 2019;14:e0224505.
    >> Share

  422. YLOSMAKI L, Polini B, Carpi S, Martins B, et al
    Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy.
    PLoS One. 2019;14:e0224072.
    >> Share

  423. PETROVIC K, Robinson J, Whitworth K, Jinks E, et al
    TEM8/ANTXR1-specific CAR T cells mediate toxicity in vivo.
    PLoS One. 2019;14:e0224015.
    >> Share

  424. IWATA TN, Sugihara K, Wada T, Agatsuma T, et al
    [Fam-] trastuzumab deruxtecan (DS-8201a)-induced antitumor immunity is facilitated by the anti-CTLA-4 antibody in a mouse model.
    PLoS One. 2019;14:e0222280.
    >> Share

  425. ALHAKAMY NA, Fahmy UA, Ahmed OAA
    Vitamin E TPGS based transferosomes augmented TAT as a promising delivery system for improved transdermal delivery of raloxifene.
    PLoS One. 2019;14:e0226639.
    >> Share

  426. NAKAMOTO S, Hirose M
    Prediction of early C-reactive protein levels after non-cardiac surgery under general anesthesia.
    PLoS One. 2019;14:e0226032.
    >> Share

    January 2018
  427. OLIVEIRA MMF, Gurgel MSC, Amorim BJ, Ramos CD, et al
    Long term effects of manual lymphatic drainage and active exercises on physical morbidities, lymphoscintigraphy parameters and lymphedema formation in patients operated due to breast cancer: A clinical trial.
    PLoS One. 2018;13:e0189176.
    >> Share

  428. THAKUR SS, Li H, Chan AMY, Tudor R, et al
    The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.
    PLoS One. 2018;13:e0188983.
    >> Share

  429. SANNACHI L, Gangeh M, Tadayyon H, Sadeghi-Naini A, et al
    Response monitoring of breast cancer patients receiving neoadjuvant chemotherapy using quantitative ultrasound, texture, and molecular features.
    PLoS One. 2018;13:e0189634.
    >> Share

  430. HADJIALIREZAEI S, Picco G, Beatson R, Burchell J, et al
    Correction: Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.
    PLoS One. 2018;13:e0190814.
    >> Share

  431. KROIGARD AB, Larsen MJ, Laenkholm AV, Knoop AS, et al
    Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression.
    PLoS One. 2018;13:e0189887.
    >> Share

  432. BROMBERG SE, Moraes PRAF, Ades F
    Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgery.
    PLoS One. 2018;13:e0191056.
    >> Share

  433. HILDENBRAND G, Metzler P, Pilarczyk G, Bobu V, et al
    Dose enhancement effects of gold nanoparticles specifically targeting RNA in breast cancer cells.
    PLoS One. 2018;13:e0190183.
    >> Share

  434. LI T, Zhao J, Yang J, Ma X, et al
    Correction: A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
    PLoS One. 2018;13:e0191579.
    >> Share

  435. KHALIS M, Charbotel B, Chajes V, Rinaldi S, et al
    Menstrual and reproductive factors and risk of breast cancer: A case-control study in the Fez region, Morocco.
    PLoS One. 2018;13:e0191333.
    >> Share

  436. TSAI HP, Huang SF, Li CF, Chien HT, et al
    Differential microRNA expression in breast cancer with different onset age.
    PLoS One. 2018;13:e0191195.
    >> Share

  437. SYED BM, Morgan D, Setty T, Green AR, et al
    Correction: Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.
    PLoS One. 2018;13:e0191979.
    >> Share

  438. KIM J, Choi SH, Ham SJ, Cho YC, et al
    Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, TTAC-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model.
    PLoS One. 2018;13:e0187063.
    >> Share

  439. BOUGARET L, Delort L, Billard H, Le Huede C, et al
    Adipocyte/breast cancer cell crosstalk in obesity interferes with the anti-proliferative efficacy of tamoxifen.
    PLoS One. 2018;13:e0191571.
    >> Share

  440. KHAN MM, Mendes A, Chalup SK
    Evolutionary Wavelet Neural Network ensembles for breast cancer and Parkinson's disease prediction.
    PLoS One. 2018;13:e0192192.
    >> Share

  441. RUSSO-ABRAHAO T, Lacerda-Abreu MA, Gomes T, Cosentino-Gomes D, et al
    Characterization of inorganic phosphate transport in the triple-negative breast cancer cell line, MDA-MB-231.
    PLoS One. 2018;13:e0191270.
    >> Share

  442. BELCHER DA, Ju JA, Baek JH, Yalamanoglu A, et al
    The quaternary state of polymerized human hemoglobin regulates oxygenation of breast cancer solid tumors: A theoretical and experimental study.
    PLoS One. 2018;13:e0191275.
    >> Share

  443. BRADFORD JR, Cox A, Bernard P, Camp NJ, et al
    Correction: Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
    PLoS One. 2018;13:e0192589.
    >> Share

  444. ZHANG J, Yang J, Zhang X, Xu J, et al
    MicroRNA-10b expression in breast cancer and its clinical association.
    PLoS One. 2018;13:e0192509.
    >> Share

  445. JOFFE M, Ayeni O, Norris SA, McCormack VA, et al
    Barriers to early presentation of breast cancer among women in Soweto, South Africa.
    PLoS One. 2018;13:e0192071.
    >> Share

  446. PATEL N, Garikapati KR, Makani VKK, Nair AD, et al
    Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug.
    PLoS One. 2018;13:e0190245.
    >> Share

  447. VACHER S, Castagnet P, Chemlali W, Lallemand F, et al
    High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism.
    PLoS One. 2018;13:e0190619.
    >> Share

  448. THAKRAN S, Chatterjee S, Singhal M, Gupta RK, et al
    Automatic outer and inner breast tissue segmentation using multi-parametric MRI images of breast tumor patients.
    PLoS One. 2018;13:e0190348.
    >> Share

  449. CALA MP, Aldana J, Medina J, Sanchez J, et al
    Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women.
    PLoS One. 2018;13:e0190958.
    >> Share

  450. ROHAN T, Ye K, Wang Y, Glass AG, et al
    MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer.
    PLoS One. 2018;13:e0191814.
    >> Share

  451. YUAN H, Chen V, Boisvert M, Isaacs C, et al
    PLAC1 as a serum biomarker for breast cancer.
    PLoS One. 2018;13:e0192106.
    >> Share

  452. ZIAI J, Gilbert HN, Foreman O, Eastham-Anderson J, et al
    CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.
    PLoS One. 2018;13:e0190158.
    >> Share

  453. HO PJ, Hartman M, Young-Afat DA, Gernaat SAM, et al
    Determinants of satisfaction with cosmetic outcome in breast cancer survivors: A cross-sectional study.
    PLoS One. 2018;13:e0193099.
    >> Share

  454. JENSEN-JOHANSEN MB, O'Toole MS, Christensen S, Valdimarsdottir H, et al
    Expressive writing intervention and self-reported physical health out-comes - Results from a nationwide randomized controlled trial with breast cancer patients.
    PLoS One. 2018;13:e0192729.
    >> Share

  455. DE GROEF A, Van Kampen M, Moortgat P, Anthonissen M, et al
    An evaluation tool for Myofascial Adhesions in Patients after Breast Cancer (MAP-BC evaluation tool): Concurrent, face and content validity.
    PLoS One. 2018;13:e0193915.
    >> Share

  456. BOSE C, Awasthi S, Sharma R, Benes H, et al
    Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model.
    PLoS One. 2018;13:e0193918.
    >> Share

  457. HUSSAIN A, Yong C, Tkaczuk KHR, Qian Y, et al
    Prevalence and risk of skeletal complications and use of radiation therapy in elderly women diagnosed with metastatic breast cancer.
    PLoS One. 2018;13:e0193661.
    >> Share

  458. ALMOTWAA S, Elrobh M, AbdulKarim H, Alanazi M, et al
    Genetic polymorphism and expression of HSF1 gene is significantly associated with breast cancer in Saudi females.
    PLoS One. 2018;13:e0193095.
    >> Share

  459. VREEMANN S, Gubern-Merida A, Borelli C, Bult P, et al
    The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers.
    PLoS One. 2018;13:e0191399.
    >> Share

  460. LAGUNIN AA, Dubovskaja VI, Rudik AV, Pogodin PV, et al
    CLC-Pred: A freely available web-service for in silico prediction of human cell line cytotoxicity for drug-like compounds.
    PLoS One. 2018;13:e0191838.
    >> Share

  461. ZHAO X, Wei J, Li X, Yang H, et al
    Increasing negative lymph node count predicts favorable OS and DSS in breast cancer with different lymph node-positive subgroups.
    PLoS One. 2018;13:e0193784.
    >> Share

  462. HELLEC C, Delos M, Carpentier M, Denys A, et al
    The heparan sulfate 3-O-sulfotransferases (HS3ST) 2, 3B and 4 enhance proliferation and survival in breast cancer MDA-MB-231 cells.
    PLoS One. 2018;13:e0194676.
    >> Share

  463. MAHMUD A, Aljunid SM
    Availability and accessibility of subsidized mammogram screening program in peninsular Malaysia: A preliminary study using travel impedance approach.
    PLoS One. 2018;13:e0191764.
    >> Share

  464. DVORAK KM, Pettee KM, Rubinic-Minotti K, Su R, et al
    Carcinoma associated fibroblasts (CAFs) promote breast cancer motility by suppressing mammalian Diaphanous-related formin-2 (mDia2).
    PLoS One. 2018;13:e0195278.
    >> Share

  465. ARYAL B, Rao VA
    Specific protein carbonylation in human breast cancer tissue compared to adjacent healthy epithelial tissue.
    PLoS One. 2018;13:e0194164.
    >> Share

  466. TAMEZ-PENA JG, Rodriguez-Rojas JA, Gomez-Rueda H, Celaya-Padilla JM, et al
    Radiogenomics analysis identifies correlations of digital mammography with clinical molecular signatures in breast cancer.
    PLoS One. 2018;13:e0193871.
    >> Share

  467. KHAJAH MA, Mathew PM, Luqmani YA
    Na+/K+ ATPase activity promotes invasion of endocrine resistant breast cancer cells.
    PLoS One. 2018;13:e0193779.
    >> Share

  468. NGUYEN CP, Adang EMM
    Cost-effectiveness of breast cancer screening using mammography in Vietnamese women.
    PLoS One. 2018;13:e0194996.
    >> Share

  469. BROMBERG SE, Moraes PRAF, Ades F
    Correction: Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgery.
    PLoS One. 2018;13:e0195130.
    >> Share

  470. LUENGO-GIL G, Gonzalez-Billalabeitia E, Perez-Henarejos SA, Navarro Manzano E, et al
    Angiogenic role of miR-20a in breast cancer.
    PLoS One. 2018;13:e0194638.
    >> Share

  471. BAMBHROLIYA A, Van Wyhe RD, Kumar S, Debeb BG, et al
    Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer.
    PLoS One. 2018;13:e0192689.
    >> Share

  472. HAN Q, Chen R, Wang F, Chen S, et al
    Pre-exposure to 50 Hz-electromagnetic fields enhanced the antiproliferative efficacy of 5-fluorouracil in breast cancer MCF-7 cells.
    PLoS One. 2018;13:e0192888.
    >> Share

  473. LUCHSINGER C, Aguilar M, Burgos PV, Ehrenfeld P, et al
    Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling.
    PLoS One. 2018;13:e0195401.
    >> Share

  474. HORIBATA S, Rice EJ, Zheng H, Mukai C, et al
    A bi-stable feedback loop between GDNF, EGR1, and ERalpha contribute to endocrine resistant breast cancer.
    PLoS One. 2018;13:e0194522.
    >> Share

  475. HORIBATA S, Rice EJ, Mukai C, Marks BA, et al
    ER-positive breast cancer cells are poised for RET-mediated endocrine resistance.
    PLoS One. 2018;13:e0194023.
    >> Share

  476. NAM SY, Ko ES, Lim Y, Han BK, et al
    Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer.
    PLoS One. 2018;13:e0195756.
    >> Share

  477. CHU LW, John EM, Yang B, Kurian AW, et al
    Measuring serum melatonin in postmenopausal women: Implications for epidemiologic studies and breast cancer studies.
    PLoS One. 2018;13:e0195666.
    >> Share

  478. SANDLIN RD, Wong KHK, Tessier SN, Swei A, et al
    Ultra-fast vitrification of patient-derived circulating tumor cell lines.
    PLoS One. 2018;13:e0192734.
    >> Share

  479. SEO IS, Lee HG, Koo B, Koh CS, et al
    Cross detection for odor of metabolic waste between breast and colorectal cancer using canine olfaction.
    PLoS One. 2018;13:e0192629.
    >> Share

  480. KORONOWICZ AA, Drozdowska M, Wielgos B, Piasna-Slupecka E, et al
    The effect of "NutramilTM Complex," food for special medical purpose, on breast and prostate carcinoma cells.
    PLoS One. 2018;13:e0192860.
    >> Share

  481. DEWALD JH, Cavdarli S, Steenackers A, Delannoy CP, et al
    TNF differentially regulates ganglioside biosynthesis and expression in breast cancer cell lines.
    PLoS One. 2018;13:e0196369.
    >> Share

  482. PARISE C, Caggiano V
    The influence of marital status and race/ethnicity on risk of mortality for triple negative breast cancer.
    PLoS One. 2018;13:e0196134.
    >> Share

  483. TISSIER R, Houwing-Duistermaat J, Rodriguez-Girondo M
    Improving stability of prediction models based on correlated omics data by using network approaches.
    PLoS One. 2018;13:e0192853.
    >> Share

  484. FRICKE IB, De Souza R, Costa Ayub L, Francia G, et al
    Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
    PLoS One. 2018;13:e0196892.
    >> Share

  485. VERONESE P, Hachul DT, Scanavacca MI, Hajjar LA, et al
    Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer.
    PLoS One. 2018;13:e0196763.
    >> Share

  486. KOVAC B, Makela TP, Vallenius T
    Increased alpha-actinin-1 destabilizes E-cadherin-based adhesions and associates with poor prognosis in basal-like breast cancer.
    PLoS One. 2018;13:e0196986.
    >> Share

  487. SENARAS C, Niazi MKK, Sahiner B, Pennell MP, et al
    Optimized generation of high-resolution phantom images using cGAN: Application to quantification of Ki67 breast cancer images.
    PLoS One. 2018;13:e0196846.
    >> Share

  488. FATIMA I, El-Ayachi I, Taotao L, Angeles Lillo M, et al
    Correction: The natural compound Jatrophone interferes with Wnt/beta-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
    PLoS One. 2018;13:e0197796.
    >> Share

  489. ECKHARDT BL, Gagliardi M, Iles L, Evans K, et al
    Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.
    PLoS One. 2018;13:e0195932.
    >> Share

  490. LIM ST, Park CH, Kim SY, Nam SJ, et al
    The effect of adjuvant chemotherapy on survival in Korean patients with node negative T1c, triple negative breast cancer.
    PLoS One. 2018;13:e0197523.
    >> Share

  491. ZENG Z, Jiang X, Li X, Wells A, et al
    Conjugated equine estrogen and medroxyprogesterone acetate are associated with decreased risk of breast cancer relative to bioidentical hormone therapy and controls.
    PLoS One. 2018;13:e0197064.
    >> Share

  492. KHARMAN-BIZ A, Gao H, Ghiasvand R, Haldosen LA, et al
    Expression of the three components of linear ubiquitin assembly complex in breast cancer.
    PLoS One. 2018;13:e0197183.
    >> Share

  493. RACCAGNI I, Belloli S, Valtorta S, Stefano A, et al
    [18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer.
    PLoS One. 2018;13:e0197754.
    >> Share

  494. Retraction: Calcium Channel Blockers and Risk of Breast Cancer: A Meta-Analysis of 17 Observational Studies.
    PLoS One. 2018;13:e0198220.
    >> Share

  495. STRUIK GM, Vrijland WW, Birnie E, Klem TMAL, et al
    A randomized controlled trial on the effect of a silver carboxymethylcellulose dressing on surgical site infections after breast cancer surgery.
    PLoS One. 2018;13:e0195715.
    >> Share

  496. HUBBELING HG, Rosenberg SM, Gonzalez-Robledo MC, Cohn JG, et al
    Psychosocial needs of young breast cancer survivors in Mexico City, Mexico.
    PLoS One. 2018;13:e0197931.
    >> Share

  497. PAVANELLO S, Varesco L, Gismondi V, Bruzzi P, et al
    Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control study.
    PLoS One. 2018;13:e0197522.
    >> Share

  498. RAINEY L, van der Waal D, Donnelly LS, Evans DG, et al
    Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.
    PLoS One. 2018;13:e0197772.
    >> Share

  499. HARALDSDOTTIR A, Torfadottir JE, Valdimarsdottir UA, Adami HO, et al
    Dietary habits in adolescence and midlife and risk of breast cancer in older women.
    PLoS One. 2018;13:e0198017.
    >> Share

  500. GHOSH A, Sarkar S, Banerjee S, Behbod F, et al
    MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis.
    PLoS One. 2018;13:e0198143.
    >> Share

  501. VEYS I, Pop CF, Barbieux R, Moreau M, et al
    ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy.
    PLoS One. 2018;13:e0197857.
    >> Share

  502. ALHAMAMI M, Cheng W, Lyu Y, Allen C, et al
    Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer.
    PLoS One. 2018;13:e0196998.
    >> Share

  503. CRUZ-ROA A, Gilmore H, Basavanhally A, Feldman M, et al
    High-throughput adaptive sampling for whole-slide histopathology image analysis (HASHI) via convolutional neural networks: Application to invasive breast cancer detection.
    PLoS One. 2018;13:e0196828.
    >> Share

  504. GU S, Ngamcherdtrakul W, Reda M, Hu Z, et al
    Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment.
    PLoS One. 2018;13:e0198141.
    >> Share

  505. FORMA E, Jozwiak P, Ciesielski P, Zaczek A, et al
    Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells.
    PLoS One. 2018;13:e0198351.
    >> Share

  506. HAN X, Zhao J, Ruddy KJ, Lin CC, et al
    The impact of dependent coverage expansion under the Affordable Care Act on time to breast cancer treatment among young women.
    PLoS One. 2018;13:e0198771.
    >> Share

  507. ASTVATSATURYAN K, Yue Y, Walts AE, Bose S, et al
    Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features.
    PLoS One. 2018;13:e0197827.
    >> Share

  508. ALI S, Malik MZ, Singh SS, Chirom K, et al
    Exploring novel key regulators in breast cancer network.
    PLoS One. 2018;13:e0198525.
    >> Share

  509. EASTLACK SC, Dong S, Mo YY, Alahari SK, et al
    Expression of long noncoding RNA MALAT1 correlates with increased levels of Nischarin and inhibits oncogenic cell functions in breast cancer.
    PLoS One. 2018;13:e0198945.
    >> Share

  510. MCDONNELL SL, Baggerly CA, French CB, Baggerly LL, et al
    Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations >/=60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
    PLoS One. 2018;13:e0199265.
    >> Share

  511. HENRY TR, Marshall SA, Avis NE, Levine BJ, et al
    Concordance networks and application to clustering cancer symptomology.
    PLoS One. 2018;13:e0191981.
    >> Share

  512. LESICKA M, Jablonska E, Wieczorek E, Seroczynska B, et al
    Altered circadian genes expression in breast cancer tissue according to the clinical characteristics.
    PLoS One. 2018;13:e0199622.
    >> Share

  513. BOYNE DJ, King WD, Brenner DR, McIntyre JB, et al
    Aerobic exercise and DNA methylation in postmenopausal women: An ancillary analysis of the Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial.
    PLoS One. 2018;13:e0198641.
    >> Share

  514. LOBBA ARM, Carreira ACO, Cerqueira OLD, Fujita A, et al
    High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors.
    PLoS One. 2018;13:e0199254.
    >> Share

  515. MARTIN CL, Tate DF, Valle CG
    Nonadherence to daily self-weighing and activity tracking is associated with weight fluctuations among African American breast cancer survivors.
    PLoS One. 2018;13:e0199751.
    >> Share

  516. VOUTOURI C, Stylianopoulos T
    Accumulation of mechanical forces in tumors is related to hyaluronan content and tissue stiffness.
    PLoS One. 2018;13:e0193801.
    >> Share

  517. HORIE Y, Makihara H, Horikawa K, Takeshige F, et al
    Reduced skin lipid content in obese Japanese women mediated by decreased expression of rate-limiting lipogenic enzymes.
    PLoS One. 2018;13:e0193830.
    >> Share

  518. GODLEWSKA M, Krasuska W, Czarnocka B
    Biochemical properties of thyroid peroxidase (TPO) expressed in human breast and mammary-derived cell lines.
    PLoS One. 2018;13:e0193624.
    >> Share

  519. WITTKOWSKI KM, Dadurian C, Seybold MP, Kim HS, et al
    Complex polymorphisms in endocytosis genes suggest alpha-cyclodextrin as a treatment for breast cancer.
    PLoS One. 2018;13:e0199012.
    >> Share

  520. CHEN Z, Ai L, Mboge MY, Tu C, et al
    Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells.
    PLoS One. 2018;13:e0199476.
    >> Share

  521. TAKABAYASHI M, Majeed H, Kajdacsy-Balla A, Popescu G, et al
    Disorder strength measured by quantitative phase imaging as intrinsic cancer marker in fixed tissue biopsies.
    PLoS One. 2018;13:e0194320.
    >> Share

  522. CHOI SW, Ryu SY, Han MA, Park J, et al
    Higher breast cancer prevalence associated with higher socioeconomic status in the South Korean population; Has it resulted from overdiagnosis?
    PLoS One. 2018;13:e0200484.
    >> Share

  523. KIM YY, Oh SJ, Chun YS, Lee WK, et al
    Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer.
    PLoS One. 2018;13:e0200100.
    >> Share

  524. TYURYUMINA EY, Neznanov AA
    Consolidated mathematical growth model of the primary tumor and secondary distant metastases of breast cancer (CoMPaS).
    PLoS One. 2018;13:e0200148.
    >> Share

  525. SUN X, Stewart DA, Sandhu R, Kirk EL, et al
    Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissue.
    PLoS One. 2018;13:e0193792.
    >> Share

  526. BINDER K, Krauss S, Bruckmaier G, Marienhagen J, et al
    Visualizing the Bayesian 2-test case: The effect of tree diagrams on medical decision making.
    PLoS One. 2018;13:e0195029.
    >> Share

  527. PANNUTI A, Filipovic A, Hicks C, Lefkowitz E, et al
    Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors.
    PLoS One. 2018;13:e0194790.
    >> Share

  528. SETYOWIBOWO H, Purba FD, Hunfeld JAM, Iskandarsyah A, et al
    Quality of life and health status of Indonesian women with breast cancer symptoms before the definitive diagnosis: A comparison with Indonesian women in general.
    PLoS One. 2018;13:e0200966.
    >> Share

  529. DEPARDON E, Kanoun S, Humbert O, Bertaut A, et al
    FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST.
    PLoS One. 2018;13:e0199529.
    >> Share

  530. MITCHELL R, Buckingham L, Cobleigh M, Rotmensch J, et al
    Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?
    PLoS One. 2018;13:e0195497.
    >> Share

  531. PETURSSON HI, Kovacs A, Mattsson J, Olofsson Bagge R, et al
    Evaluation of intraoperative touch imprint cytology on axillary sentinel lymph nodes in invasive breast carcinomas, a retrospective study of 1227 patients comparing sensitivity in the different tumor subtypes.
    PLoS One. 2018;13:e0195560.
    >> Share

  532. AL-AJMI K, Lophatananon A, Ollier W, Muir KR, et al
    Risk of breast cancer in the UK biobank female cohort and its relationship to anthropometric and reproductive factors.
    PLoS One. 2018;13:e0201097.
    >> Share

  533. CHO U, Park HS, Im SY, Yoo CY, et al
    Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer.
    PLoS One. 2018;13:e0200936.
    >> Share

  534. GUO J, Liu C, Wang W, Liu Y, et al
    Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
    PLoS One. 2018;13:e0200716.
    >> Share

  535. DANIELS B, Girosi F, Tervonen H, Kiely BE, et al
    Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016).
    PLoS One. 2018;13:e0198152.
    >> Share

  536. HILTON J, Stober C, Mazzarello S, Vandermeer L, et al
    Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial).
    PLoS One. 2018;13:e0199297.
    >> Share

  537. KASSARDJIAN A, Shintaku PI, Moatamed NA
    Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas.
    PLoS One. 2018;13:e0195958.
    >> Share

  538. GOUSSIA A, Simou N, Zagouri F, Manousou K, et al
    Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial.
    PLoS One. 2018;13:e0200302.
    >> Share

  539. MESSEHA SS, Zarmouh NO, Mendonca P, Alwagdani H, et al
    The inhibitory effects of plumbagin on the NF-B pathway and CCL2 release in racially different triple-negative breast cancer cells.
    PLoS One. 2018;13:e0201116.
    >> Share

  540. SAEUI CT, Nairn AV, Galizzi M, Douville C, et al
    Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes.
    PLoS One. 2018;13:e0195812.
    >> Share

  541. OGATA H, Mitsuzuka Y, Honma N, Yoshida M, et al
    Sonographic visualization of nipple blood flow can help differentiate Paget disease from benign eczematous nipple lesions.
    PLoS One. 2018;13:e0197156.
    >> Share

  542. KUMAR V, Webb JM, Gregory A, Denis M, et al
    Automated and real-time segmentation of suspicious breast masses using convolutional neural network.
    PLoS One. 2018;13:e0195816.
    >> Share

  543. TSAI CW, Chang WS, Shen TC, Su CH, et al
    Contribution of excision repair cross-complementing group 1 genotypes to triple negative breast cancer risk.
    PLoS One. 2018;13:e0202112.
    >> Share

  544. Retraction: Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines.
    PLoS One. 2018;13:e0202299.
    >> Share

  545. LI X, Rouchka EC, Brock GN, Yan J, et al
    A combined approach with gene-wise normalization improves the analysis of RNA-seq data in human breast cancer subtypes.
    PLoS One. 2018;13:e0201813.
    >> Share

  546. UDDIN MM, Zou Y, Sharma T, Gatla HR, et al
    Proteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: Opportunity for combination therapy.
    PLoS One. 2018;13:e0201858.
    >> Share

  547. BANNOUD N, Carvelli FL, Troncoso M, Sartor T, et al
    Cation-dependent mannose-6-phosphate receptor expression and distribution are influenced by estradiol in MCF-7 breast cancer cells.
    PLoS One. 2018;13:e0201844.
    >> Share

  548. KUROZUMI S, Matsumoto H, Inoue K, Tozuka K, et al
    Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer.
    PLoS One. 2018;13:e0201846.
    >> Share

  549. COTE D, Eustace A, Toomey S, Cremona M, et al
    Germline single nucleotide polymorphisms in ERBB3 and BARD1 genes result in a worse relapse free survival response for HER2-positive breast cancer patients treated with adjuvant based docetaxel, carboplatin and trastuzumab (TCH).
    PLoS One. 2018;13:e0200996.
    >> Share

  550. FIGUEIREDO FWDS, Almeida TCDC, Schoueri JHM, Luisi C, et al
    Association between primary care coverage and breast cancer mortality in Brazil.
    PLoS One. 2018;13:e0200125.
    >> Share

  551. Retraction: Chaperonin CCT-Mediated AIB1 Folding Promotes the Growth of ERalpha-Positive Breast Cancer Cells on Hard Substrates.
    PLoS One. 2018;13:e0202617.
    >> Share

  552. GOMEZ-ACEBO I, Dierssen-Sotos T, Palazuelos C, Fernandez-Navarro P, et al
    Pigmentation phototype and prostate and breast cancer in a select Spanish population-A Mendelian randomization analysis in the MCC-Spain study.
    PLoS One. 2018;13:e0201750.
    >> Share

  553. KHALID S, Hanif R, Jabeen I, Mansoor Q, et al
    Pharmacophore modeling for identification of anti-IGF-1R drugs and in-vitro validation of fulvestrant as a potential inhibitor.
    PLoS One. 2018;13:e0196312.
    >> Share

  554. IPPOLITO E, Fiore M, Di Donato A, Silipigni S, et al
    Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system.
    PLoS One. 2018;13:e0195506.
    >> Share

  555. GOMES RS, Moreira FTC, Fernandes R, Sales MGF, et al
    Sensing CA 15-3 in point-of-care by electropolymerizing O-phenylenediamine (oPDA) on Au-screen printed electrodes.
    PLoS One. 2018;13:e0196656.
    >> Share

  556. TARIQ H, Eldridge E, Welch I
    An efficient approach for feature construction of high-dimensional microarray data by random projections.
    PLoS One. 2018;13:e0196385.
    >> Share

  557. PANDE M, Joon A, Brewster AM, Chen WV, et al
    Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.
    PLoS One. 2018;13:e0196245.
    >> Share

  558. YANG J, Min KW, Kim DH, Son BK, et al
    High TNFRSF12A level associated with MMP-9 overexpression is linked to poor prognosis in breast cancer: Gene set enrichment analysis and validation in large-scale cohorts.
    PLoS One. 2018;13:e0202113.
    >> Share

  559. CARIOU A, Rouzier R, Baffert S, Soilly AL, et al
    Multidimensional impact of breast cancer screening: Results of the multicenter prospective optisoins01 study.
    PLoS One. 2018;13:e0202385.
    >> Share

  560. RANASINGHE SL, Boyle GM, Fischer K, Potriquet J, et al
    Kunitz type protease inhibitor EgKI-1 from the canine tapeworm Echinococcus granulosus as a promising therapeutic against breast cancer.
    PLoS One. 2018;13:e0200433.
    >> Share

  561. COBO-CUENCA AI, Martin-Espinosa NM, Sampietro-Crespo A, Rodriguez-Borrego MA, et al
    Sexual dysfunction in Spanish women with breast cancer.
    PLoS One. 2018;13:e0203151.
    >> Share

  562. SMITH A, Mullooly M, Murphy L, Barron TI, et al
    Associations between obesity, smoking and lymph node status at breast cancer diagnosis in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    PLoS One. 2018;13:e0202291.
    >> Share

  563. KOUSSEMOU M, Lorenz K, Klotz KN
    The A2B adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1/2 phosphorylation by activation of MAPK-phosphatase-1.
    PLoS One. 2018;13:e0202914.
    >> Share

  564. BLACKBURN NE, Mc Veigh JG, Mc Caughan EM, Kennedy RD, et al
    The musculoskeletal consequences of latissmus dorsi breast reconstruction in women following mastectomy for breast cancer.
    PLoS One. 2018;13:e0202859.
    >> Share

  565. SCIOLI MG, Artuso S, D'Angelo C, Porru M, et al
    Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth.
    PLoS One. 2018;13:e0203426.
    >> Share

  566. TAMAYO LI, Vidaurre T, Navarro Vasquez J, Casavilca S, et al
    Breast cancer subtype and survival among Indigenous American women in Peru.
    PLoS One. 2018;13:e0201287.
    >> Share

  567. XU S, Thompson W, Kerr J, Godbole S, et al
    Modeling interrelationships between health behaviors in overweight breast cancer survivors: Applying Bayesian networks.
    PLoS One. 2018;13:e0202923.
    >> Share

  568. MON AM, MacKinnon AC Jr, Traktman P
    Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells.
    PLoS One. 2018;13:e0203397.
    >> Share

  569. GONG IY, Fox NS, Huang V, Boutros PC, et al
    Prediction of early breast cancer patient survival using ensembles of hypoxia signatures.
    PLoS One. 2018;13:e0204123.
    >> Share

  570. TAN MM, Ho WK, Yoon SY, Mariapun S, et al
    A case-control study of breast cancer risk factors in 7,663 women in Malaysia.
    PLoS One. 2018;13:e0203469.
    >> Share

  571. LI G, Guo X, Chen M, Tang L, et al
    Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients.
    PLoS One. 2018;13:e0203495.
    >> Share

  572. YOO J, Kim BS, Chung J, Yoon HJ, et al
    Clinical value of delayed 18F-FDG PET/CT for predicting nipple-areolar complex involvement in breast cancer: A comparison with clinical symptoms and breast MRI.
    PLoS One. 2018;13:e0203649.
    >> Share

  573. LI J, Chen X, Qi M, Li Y, et al
    Sentinel lymph node biopsy mapped with methylene blue dye alone in patients with breast cancer: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0204364.
    >> Share

  574. CHANCHAN G, Xiangyu S, Fangfang S, Yan C, et al
    The efficacy and safety of targeted therapy plus fulvestrant in postmenopausal women with hormone-receptor positive advanced breast cancer: A meta-analysis of randomized-control trials.
    PLoS One. 2018;13:e0204202.
    >> Share

  575. CALAHORRA J, Martinez-Lara E, De Dios C, Siles E, et al
    Hypoxia modulates the antioxidant effect of hydroxytyrosol in MCF-7 breast cancer cells.
    PLoS One. 2018;13:e0203892.
    >> Share

  576. DING LY, Chu M, Jiao YS, Hao Q, et al
    TFDP3 regulates the apoptosis and autophagy in breast cancer cell line MDA-MB-231.
    PLoS One. 2018;13:e0203833.
    >> Share

  577. LIN PH, Yang HJ, Hsieh WC, Lin C, et al
    Albumin and hemoglobin adducts of estrogen quinone as biomarkers for early detection of breast cancer.
    PLoS One. 2018;13:e0201241.
    >> Share

  578. FOUAD TM, Ueno NT, Yu RK, Ensor JE, et al
    Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center.
    PLoS One. 2018;13:e0204372.
    >> Share

  579. KAZEMI NOUREINI S, Fatemi L, Wink M
    Telomere shortening in breast cancer cells (MCF7) under treatment with low doses of the benzylisoquinoline alkaloid chelidonine.
    PLoS One. 2018;13:e0204901.
    >> Share

  580. Retraction: Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1alpha Accumulation via Increased Production of Reactive Oxygen Species.
    PLoS One. 2018;13:e0205288.
    >> Share

  581. GOKMEN-POLAR Y, True JD, Vieth E, Gu Y, et al
    Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer.
    PLoS One. 2018;13:e0204658.
    >> Share

  582. COLLIGNON O, Han J, An H, Oh S, et al
    Comparison of the modified unbounded penalty and the LASSO to select predictive genes of response to chemotherapy in breast cancer.
    PLoS One. 2018;13:e0204897.
    >> Share

  583. ANSARIPOUR A, Zendehdel K, Tadayon N, Sadeghi F, et al
    Use of data-mining to support real-world cost analyses: An example using HER2-positive breast cancer in Iran.
    PLoS One. 2018;13:e0205079.
    >> Share

  584. ZUGNI F, Ruju F, Pricolo P, Alessi S, et al
    The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer.
    PLoS One. 2018;13:e0205251.
    >> Share

  585. HARANO K, Wang Y, Lim B, Seitz RS, et al
    Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype.
    PLoS One. 2018;13:e0204513.
    >> Share

  586. VAN TREUREN T, Vishwanatha JK
    CRISPR deletion of MIEN1 in breast cancer cells.
    PLoS One. 2018;13:e0204976.
    >> Share

  587. HARALDSDOTTIR A, Torfadottir JE, Valdimarsdottir UA, Adami HO, et al
    Correction: Dietary habits in adolescence and midlife and risk of breast cancer in older women.
    PLoS One. 2018;13:e0206026.
    >> Share

  588. ALOTAIBI RM, Rezk HR, Juliana CI, Guure C, et al
    Breast cancer mortality in Saudi Arabia: Modelling observed and unobserved factors.
    PLoS One. 2018;13:e0206148.
    >> Share

  589. DUMANE VA, Bakst R, Green S
    Dose to organs in the supraclavicular region when covering the Internal Mammary Nodes (IMNs) in breast cancer patients: A comparison of Volumetric Modulated Arc Therapy (VMAT) versus 3D and VMAT.
    PLoS One. 2018;13:e0205770.
    >> Share

  590. COVARRUBIAS G, Cha A, Rahmy A, Lorkowski M, et al
    Imaging breast cancer using a dual-ligand nanochain particle.
    PLoS One. 2018;13:e0204296.
    >> Share

  591. SEMLALI A, Almutairi M, Rouabhia M, Reddy Parine N, et al
    Novel sequence variants in the TLR6 gene associated with advanced breast cancer risk in the Saudi Arabian population.
    PLoS One. 2018;13:e0203376.
    >> Share

  592. ROCHA-BRISCHILIARI SC, Andrade L, Nihei OK, Brischiliari A, et al
    Spatial distribution of breast cancer mortality: Socioeconomic disparities and access to treatment in the state of Parana, Brazil.
    PLoS One. 2018;13:e0205253.
    >> Share

  593. VENUGOPAL V, Krishnan S, Palanimuthu VR, Sankarankutty S, et al
    Anti-EGFR anchored paclitaxel loaded PLGA nanoparticles for the treatment of triple negative breast cancer. In-vitro and in-vivo anticancer activities.
    PLoS One. 2018;13:e0206109.
    >> Share

  594. BEZERRA IC, da Silva RM, Oliveira CP, Brasil CCP, et al
    Mastectomized women's perception of breast cancer early detection.
    PLoS One. 2018;13:e0206405.
    >> Share

  595. SALAGAME U, Banks E, O'Connell DL, Egger S, et al
    Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study.
    PLoS One. 2018;13:e0205034.
    >> Share

  596. CUELLO-LOPEZ J, Fidalgo-Zapata A, Lopez-Agudelo L, Vasquez-Trespalacios E, et al
    Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer.
    PLoS One. 2018;13:e0207224.
    >> Share

  597. Correction: Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer.
    PLoS One. 2018;13:e0206720.
    >> Share

  598. CAMPOS-RODRIGUEZ F, Cruz-Medina A, Selma MJ, Rodriguez-de-la-Borbolla-Artacho M, et al
    Association between sleep-disordered breathing and breast cancer aggressiveness.
    PLoS One. 2018;13:e0207591.
    >> Share

  599. KWON MJ, Lee SB, Han J, Lee JE, et al
    BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.
    PLoS One. 2018;13:e0207155.
    >> Share

  600. ALSHAREEDA AT, Rakha E, Alghwainem A, Alrfaei B, et al
    The effect of human placental chorionic villi derived mesenchymal stem cell on triple-negative breast cancer hallmarks.
    PLoS One. 2018;13:e0207593.
    >> Share

  601. MBOGE MY, Chen Z, Wolff A, Mathias JV, et al
    Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: Disconnect between activity and growth inhibition.
    PLoS One. 2018;13:e0207417.
    >> Share

  602. GROSSE FRIE K, Kamate B, Traore CB, Ly M, et al
    Factors associated with time to first healthcare visit, diagnosis and treatment, and their impact on survival among breast cancer patients in Mali.
    PLoS One. 2018;13:e0207928.
    >> Share

  603. GOKAL K, Munir F, Ahmed S, Kancherla K, et al
    Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial.
    PLoS One. 2018;13:e0206874.
    >> Share

  604. SUN L, Legood R, Dos-Santos-Silva I, Gaiha SM, et al
    Global treatment costs of breast cancer by stage: A systematic review.
    PLoS One. 2018;13:e0207993.
    >> Share

  605. DAVIS M, Tripathi S, Hughley R, He Q, et al
    AR negative triple negative or "quadruple negative" breast cancers in African American women have an enriched basal and immune signature.
    PLoS One. 2018;13:e0196909.
    >> Share

  606. BALOGH KN, Templeton DJ, Cross JV
    Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses.
    PLoS One. 2018;13:e0197702.
    >> Share

  607. KOUTRAS A, Lazaridis G, Koliou GA, Kouvatseas G, et al
    Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.
    PLoS One. 2018;13:e0207707.
    >> Share

  608. BOU-DARGHAM MJ, Liu Y, Sang QA, Zhang J, et al
    Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3.
    PLoS One. 2018;13:e0207799.
    >> Share

  609. MADDEN JM, Duffy MJ, Zgaga L, Bennett K, et al
    Trends in vitamin D supplement use in a general female and breast cancer population in Ireland: A repeated cross-sectional study.
    PLoS One. 2018;13:e0209033.
    >> Share

  610. CINGIR KOKER S, Jahja E, Shehwana H, Keskus AG, et al
    Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) RNAi is associated with cell cycle inhibition, apoptosis, DNA damage response and drug sensitivity in breast cancer.
    PLoS One. 2018;13:e0208982.
    >> Share

  611. BANG JI, Yoon HJ, Kim BS
    Clinical utility of FDG uptake within reticuloendothelial system on F-18 FDG PET/CT for prediction of tumor recurrence in breast cancer.
    PLoS One. 2018;13:e0208861.
    >> Share

  612. DE MEULENAERE V, Neyt S, Vandeghinste B, Mollet P, et al
    Species-dependent extracranial manifestations of a brain seeking breast cancer cell line.
    PLoS One. 2018;13:e0208340.
    >> Share

  613. WALKER AK, Chang A, Ziegler AI, Dhillon HM, et al
    Low dose aspirin blocks breast cancer-induced cognitive impairment in mice.
    PLoS One. 2018;13:e0208593.
    >> Share

  614. QIU L, Levine K, Gajiwala KS, Cronin CN, et al
    Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers.
    PLoS One. 2018;13:e0198374.
    >> Share

  615. PRAGER M, Kiechle M, Stollenwerk B, Hinzen C, et al
    Costs and effects of intra-operative fluorescence molecular imaging - A model-based, early assessment.
    PLoS One. 2018;13:e0198137.
    >> Share

  616. MYUNG Y, Son Y, Nam TH, Kang E, et al
    Objective assessment of flap volume changes and aesthetic results after adjuvant radiation therapy in patients undergoing immediate autologous breast reconstruction.
    PLoS One. 2018;13:e0197615.
    >> Share

  617. SRIMUNINNIMIT V, Pornpraserthsuk P, Chaiwerawattana A, Kongdan Y, et al
    Real-life clinical pattern, management, and survival in Thai patients with early-stage or metastatic triple-negative breast cancer.
    PLoS One. 2018;13:e0209040.
    >> Share

  618. CHEN FP, Chien MH, Chen HY, Ng YT, et al
    Effects of phthalates on normal human breast cells co-cultured with different fibroblasts.
    PLoS One. 2018;13:e0199596.
    >> Share

  619. HAHN EC, Bittar CM, Vianna FSL, Netto CBO, et al
    TP53 p.Arg337His germline mutation prevalence in Southern Brazil: Further evidence for mutation testing in young breast cancer patients.
    PLoS One. 2018;13:e0209934.
    >> Share

  620. BERTAUT A, Coudert J, Bengrine L, Dancourt V, et al
    Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    PLoS One. 2018;13:e0198939.
    >> Share

  621. TEA MM, Tan YY, Staudigl C, Eibl B, et al
    Improving comprehension of genetic counseling for hereditary breast and ovarian cancer clients with a visual tool.
    PLoS One. 2018;13:e0200559.
    >> Share

  622. ONISHI H, Udagawa C, Kubo M, Nakamura S, et al
    A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study.
    PLoS One. 2018;13:e0201606.
    >> Share

  623. HONG JH, Ko YH, Kang K
    RNA variant identification discrepancy among splice-aware alignment algorithms.
    PLoS One. 2018;13:e0201822.
    >> Share

  624. BISWENGER V, Baumann N, Jurschick J, Hackl M, et al
    Characterization of EGF-guided MDA-MB-231 cell chemotaxis in vitro using a physiological and highly sensitive assay system.
    PLoS One. 2018;13:e0203040.
    >> Share

  625. NAGORSKI J, Allen GI
    Genomic region detection via Spatial Convex Clustering.
    PLoS One. 2018;13:e0203007.
    >> Share

  626. JOSE V, Fumagalli D, Rothe F, Majjaj S, et al
    Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays.
    PLoS One. 2018;13:e0203346.
    >> Share

  627. XIE L, Sun Z, Hong Z, Brown NJ, et al
    Temporal and molecular dynamics of human metastatic breast carcinoma cell adhesive interactions with human bone marrow endothelium analyzed by single-cell force spectroscopy.
    PLoS One. 2018;13:e0204418.
    >> Share

  628. JUNG H, Kim B, Lee I, Yoo M, et al
    Detection of masses in mammograms using a one-stage object detector based on a deep convolutional neural network.
    PLoS One. 2018;13:e0203355.
    >> Share

  629. SERGANOVA I, Cohen IJ, Vemuri K, Shindo M, et al
    LDH-A regulates the tumor microenvironment via HIF-signaling and modulates the immune response.
    PLoS One. 2018;13:e0203965.
    >> Share

  630. OU J, Si Y, Goh K, Yasui N, et al
    Bioprocess development of antibody-drug conjugate production for cancer treatment.
    PLoS One. 2018;13:e0206246.
    >> Share

  631. ALKARAKOOLY Z, Al-Anbaky QA, Kannan K, Ali N, et al
    Metabolic reprogramming by Dichloroacetic acid potentiates photodynamic therapy of human breast adenocarcinoma MCF-7 cells.
    PLoS One. 2018;13:e0206182.
    >> Share

  632. JINESH GG, Flores ER, Brohl AS
    Chromosome 19 miRNA cluster and CEBPB expression specifically mark and potentially drive triple negative breast cancers.
    PLoS One. 2018;13:e0206008.
    >> Share

  633. JOO MW, Kang YK, Ogura K, Iwata S, et al
    Post-radiation sarcoma: A study by the Eastern Asian Musculoskeletal Oncology Group.
    PLoS One. 2018;13:e0204927.
    >> Share

  634. DHAGE S, Ernlund A, Ruggles K, Axelrod D, et al
    A genomic ruler to assess oncogenic transition between breast tumor and stroma.
    PLoS One. 2018;13:e0205602.
    >> Share

  635. KUMAR V, Denis M, Gregory A, Bayat M, et al
    Viscoelastic parameters as discriminators of breast masses: Initial human study results.
    PLoS One. 2018;13:e0205717.
    >> Share

  636. COTTU PH, Bonneterre J, Varga A, Campone M, et al
    Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.
    PLoS One. 2018;13:e0204973.
    >> Share

  637. STARLARD-DAVENPORT A, Allman R, Dite GS, Hopper JL, et al
    Validation of a genetic risk score for Arkansas women of color.
    PLoS One. 2018;13:e0204834.
    >> Share

  638. WANG K, Duan X, Gao F, Wang W, et al
    Dissecting cancer heterogeneity based on dimension reduction of transcriptomic profiles using extreme learning machines.
    PLoS One. 2018;13:e0203824.
    >> Share

  639. BURTON LJ, Hawsawi O, Loyd Q, Henderson V, et al
    Association of Epithelial Mesenchymal Transition with prostate and breast health disparities.
    PLoS One. 2018;13:e0203855.
    >> Share

  640. VILLANUEVA PJ, Martinez A, Baca ST, DeJesus RE, et al
    Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis.
    PLoS One. 2018;13:e0206467.
    >> Share

  641. CHIANG YS, Huang YF, Midha MK, Chen TH, et al
    Single cell transcriptome analysis of MCF-7 reveals consistently and inconsistently expressed gene groups each associated with distinct cellular localization and functions.
    PLoS One. 2018;13:e0199471.
    >> Share

  642. LIN ZP, Zhu YL, Lo YC, Moscarelli J, et al
    Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer.
    PLoS One. 2018;13:e0207399.
    >> Share

  643. HUANG MH, Blackwood J, Godoshian M, Pfalzer L, et al
    Factors associated with self-reported falls, balance or walking difficulty in older survivors of breast, colorectal, lung, or prostate cancer: Results from Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.
    PLoS One. 2018;13:e0208573.
    >> Share

    January 2017
  644. SU S, Bao H, Wang X, Wang Z, et al
    The quality of invasive breast cancer care for low reimbursement rate patients: A retrospective study.
    PLoS One. 2017;12:e0184866.
    >> Share

  645. ZEIDAN AM, Long JB, Wang R, Hu X, et al
    Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study.
    PLoS One. 2017;12:e0184747.
    >> Share

  646. LEFTIN A, Ben-Chetrit N, Klemm F, Joyce JA, et al
    Iron imaging reveals tumor and metastasis macrophage hemosiderin deposits in breast cancer.
    PLoS One. 2017;12:e0184765.
    >> Share

  647. FUKADA I, Ito Y, Kobayashi K, Shibayama T, et al
    The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel.
    PLoS One. 2017;12:e0184322.
    >> Share

  648. LU S, Qian Y, Huang X, Yu H, et al
    The association of dietary pattern and breast cancer in Jiangsu, China: A population-based case-control study.
    PLoS One. 2017;12:e0184453.
    >> Share

  649. POPOLIN CP, Reis JPB, Becceneri AB, Graminha AE, et al
    Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    PLoS One. 2017;12:e0183275.
    >> Share

  650. GOTZ TI, Lahmer G, Strnad V, Bert C, et al
    A tool to automatically analyze electromagnetic tracking data from high dose rate brachytherapy of breast cancer patients.
    PLoS One. 2017;12:e0183608.
    >> Share

  651. PARK NJ, Chang Y, Bender C, Conley Y, et al
    Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health Initiative.
    PLoS One. 2017;12:e0184174.
    >> Share

  652. BUONOMO OC, Caredda E, Portarena I, Vanni G, et al
    New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes.
    PLoS One. 2017;12:e0184680.
    >> Share

  653. PADALA C, Tupurani MA, Puranam K, Gantala S, et al
    Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
    PLoS One. 2017;12:e0184448.
    >> Share

  654. FUJII T, Reuben JM, Huo L, Espinosa Fernandez JR, et al
    Androgen receptor expression on circulating tumor cells in metastatic breast cancer.
    PLoS One. 2017;12:e0185231.
    >> Share

  655. LAMPA M, Arlt H, He T, Ospina B, et al
    Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
    PLoS One. 2017;12:e0185092.
    >> Share

  656. SCHMITZ AMT, Veldhuis WB, Menke-Pluijmers MBE, van der Kemp WJM, et al
    Preoperative indication for systemic therapy extended to patients with early-stage breast cancer using multiparametric 7-tesla breast MRI.
    PLoS One. 2017;12:e0183855.
    >> Share

  657. GSCHWANTLER-KAULICH D, Weingartshofer S, Grunt TW, Mairhofer M, et al
    Estradiol impairs the antiproliferative and proapoptotic effect of Zoledronic acid in hormone sensitive breast cancer cells in vitro.
    PLoS One. 2017;12:e0185566.
    >> Share

  658. SUCHANSKI J, Tejchman A, Zacharski M, Piotrowska A, et al
    Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression.
    PLoS One. 2017;12:e0184970.
    >> Share

  659. ZHANG W, Wang W, Chai W, Luo X, et al
    Breast tissue ablation with irreversible electroporation in rabbits: A safety and feasibility study.
    PLoS One. 2017;12:e0181555.
    >> Share

  660. DI NAPOLI A, Pepe G, Giarnieri E, Cippitelli C, et al
    Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma.
    PLoS One. 2017;12:e0181097.
    >> Share

  661. SANO H, Goto R, Hamashima C
    Does lack of resources impair access to breast and cervical cancer screening in Japan?
    PLoS One. 2017;12:e0180819.
    >> Share

  662. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    >> Share

  663. MARQUEZ-RODAS I, Pollan M, Escudero MJ, Ruiz A, et al
    Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Alamo III" retrospective study.
    PLoS One. 2017;12:e0184181.
    >> Share

  664. CILEK EE, Ozturk H, Gur Dedeoglu B
    Construction of miRNA-miRNA networks revealing the complexity of miRNA-mediated mechanisms in trastuzumab treated breast cancer cell lines.
    PLoS One. 2017;12:e0185558.
    >> Share

  665. AUKES K, Forsman C, Brady NJ, Astleford K, et al
    Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions.
    PLoS One. 2017;12:e0185736.
    >> Share

  666. KORKOLA JE, Collisson EA, Heiser LM, Oates C, et al
    Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.
    PLoS One. 2017;12:e0186551.
    >> Share

  667. QIAO W, Jia Z, Liu H, Liu Q, et al
    Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
    PLoS One. 2017;12:e0186191.
    >> Share

  668. XIE F, Hosany S, Zhong S, Jiang Y, et al
    MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1.
    PLoS One. 2017;12:e0185565.
    >> Share

  669. THIRUNAVUKKARASAN M, Wang C, Rao A, Hind T, et al
    Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells.
    PLoS One. 2017;12:e0186334.
    >> Share

  670. MAHAJAN AS, Sugita BM, Duttargi AN, Saenz F, et al
    Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors.
    PLoS One. 2017;12:e0186190.
    >> Share

  671. RAZAZAN A, Behravan J, Arab A, Barati N, et al
    Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.
    PLoS One. 2017;12:e0185099.
    >> Share

  672. HEQUET D, Callens C, Gentien D, Albaud B, et al
    Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna(R) Test in the management of early-stage breast cancers.
    PLoS One. 2017;12:e0185753.
    >> Share

  673. PEARCE A, Haas M, Viney R, Pearson SA, et al
    Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.
    PLoS One. 2017;12:e0184360.
    >> Share

  674. VALIANATOS G, Valcikova B, Growkova K, Verlande A, et al
    A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein.
    PLoS One. 2017;12:e0185801.
    >> Share

  675. HEBBRECHT T, Van Audenhove I, Zwaenepoel O, Verhelle A, et al
    VCA nanobodies target N-WASp to reduce invadopodium formation and functioning.
    PLoS One. 2017;12:e0185076.
    >> Share

  676. NISHIMUKAI A, Inoue N, Kira A, Takeda M, et al
    Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.
    PLoS One. 2017;12:e0184508.
    >> Share

  677. SERRANO-GOMEZ SJ, Sanabria-Salas MC, Garay J, Baddoo MC, et al
    Ancestry as a potential modifier of gene expression in breast tumors from Colombian women.
    PLoS One. 2017;12:e0183179.
    >> Share

  678. DIMITROPOULOS K, Barmpoutis P, Zioga C, Kamas A, et al
    Grading of invasive breast carcinoma through Grassmannian VLAD encoding.
    PLoS One. 2017;12:e0185110.
    >> Share

  679. KANG HJ, Kim SW, Son SH
    The feasibility of a heart block with an electron compensation as an alternative whole breast radiotherapy technique in patients with underlying cardiac or pulmonary disease.
    PLoS One. 2017;12:e0184137.
    >> Share

  680. CHEN Z, Yang J, Li S, Lv M, et al
    Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.
    PLoS One. 2017;12:e0182397.
    >> Share

  681. PARK JM, Bae SJ, Yoon C, Lee HS, et al
    Comparison of patients with small (</=2 cm) breast cancer according to adherence to breast screening program.
    PLoS One. 2017;12:e0186988.
    >> Share

  682. LAI HW, Liu LC, Ouyang F, Yao CC, et al
    Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent(R) eBx(R) System for the management of early stage breast cancer in Taiwan.
    PLoS One. 2017;12:e0185876.
    >> Share

  683. HENLE AM, Nassar A, Puglisi-Knutson D, Youssef B, et al
    Downregulation of TAP1 and TAP2 in early stage breast cancer.
    PLoS One. 2017;12:e0187323.
    >> Share

  684. COIGNET MV, Zirpoli GR, Roberts MR, Khoury T, et al
    Genetic variations, reproductive aging, and breast cancer risk in African American and European American women: The Women's Circle of Health Study.
    PLoS One. 2017;12:e0187205.
    >> Share

  685. JOHANNESSEN C, Moi L, Kiselev Y, Pedersen MI, et al
    Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.
    PLoS One. 2017;12:e0186658.
    >> Share

  686. REESE DE, Henderson MC, Silver M, Mulpuri R, et al
    Breast density does not impact the ability of Videssa(R) Breast to detect breast cancer in women under age 50.
    PLoS One. 2017;12:e0186198.
    >> Share

  687. SUNG PL, Wen KC, Chen YJ, Chao TC, et al
    The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels.
    PLoS One. 2017;12:e0185615.
    >> Share

  688. LAROCHE F, Perrot S, Medkour T, Cottu PH, et al
    Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study.
    PLoS One. 2017;12:e0187165.
    >> Share

  689. WAKAI R, Ishitsuka M, Kishimoto T, Ochiai T, et al
    Identification of genes and critical control proteins associated with inflammatory breast cancer using network controllability.
    PLoS One. 2017;12:e0186353.
    >> Share

  690. THERIAU CF, Sauve OS, Beaudoin MS, Wright DC, et al
    Proliferative endocrine effects of adipose tissue from obese animals on MCF7 cells are ameliorated by resveratrol supplementation.
    PLoS One. 2017;12:e0183897.
    >> Share

  691. HIRONAKA-MITSUHASHI A, Matsuzaki J, Takahashi RU, Yoshida M, et al
    A tissue microRNA signature that predicts the prognosis of breast cancer in young women.
    PLoS One. 2017;12:e0187638.
    >> Share

  692. SYED S, Schober J, Blanco A, Zustiak SP, et al
    Morphological adaptations in breast cancer cells as a function of prolonged passaging on compliant substrates.
    PLoS One. 2017;12:e0187853.
    >> Share

  693. CARLSEN JF, Ewertsen C, Sletting S, Talman ML, et al
    Strain histograms are equal to strain ratios in predicting malignancy in breast tumours.
    PLoS One. 2017;12:e0186230.
    >> Share

  694. KYEONG S, Cha YJ, Ahn SG, Suh SH, et al
    Subtypes of breast cancer show different spatial distributions of brain metastases.
    PLoS One. 2017;12:e0188542.
    >> Share

  695. THOMPSON KJ, Ingle JN, Tang X, Chia N, et al
    A comprehensive analysis of breast cancer microbiota and host gene expression.
    PLoS One. 2017;12:e0188873.
    >> Share

  696. MARINHO EDC, Custodio IDD, Ferreira IB, Crispim CA, et al
    Impact of chemotherapy on perceptions related to food intake in women with breast cancer: A prospective study.
    PLoS One. 2017;12:e0187573.
    >> Share

  697. AZIZI M, Ghourchian H, Yazdian F, Dashtestani F, et al
    Cytotoxic effect of albumin coated copper nanoparticle on human breast cancer cells of MDA-MB 231.
    PLoS One. 2017;12:e0188639.
    >> Share

  698. MAYORAL-VARO V, Calcabrini A, Sanchez-Bailon MP, Martin-Perez J, et al
    miR205 inhibits stem cell renewal in SUM159PT breast cancer cells.
    PLoS One. 2017;12:e0188637.
    >> Share

  699. ARENAS M, Garcia-Heredia A, Cabre N, Luciano-Mateo F, et al
    Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients.
    PLoS One. 2017;12:e0188633.
    >> Share

  700. AHN SG, Bae SJ, Yoon C, Cha YJ, et al
    Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay.
    PLoS One. 2017;12:e0187679.
    >> Share

  701. ZEUNE L, van Dalum G, Decraene C, Proudhon C, et al
    Quantifying HER-2 expression on circulating tumor cells by ACCEPT.
    PLoS One. 2017;12:e0186562.
    >> Share

  702. TAKEUCHI H, Abe M, Takumi Y, Hashimoto T, et al
    The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer.
    PLoS One. 2017;12:e0189166.
    >> Share

  703. KASANGIAN AA, Gherardi G, Biagioli E, Torri V, et al
    The prognostic role of tumor size in early breast cancer in the era of molecular biology.
    PLoS One. 2017;12:e0189127.
    >> Share

  704. AGARWAL S, Ying J, Boucher KM, Agarwal JP, et al
    The association between socioeconomic factors and breast cancer-specific survival varies by race.
    PLoS One. 2017;12:e0187018.
    >> Share

  705. DAVIES G, Lobanova L, Dawicki W, Groot G, et al
    Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer.
    PLoS One. 2017;12:e0187191.
    >> Share

  706. ZHANG H, Diao H, Jia L, Yuan Y, et al
    Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model.
    PLoS One. 2017;12:e0188960.
    >> Share

  707. ALEMAR B, Gregorio C, Herzog J, Matzenbacher Bittar C, et al
    BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
    PLoS One. 2017;12:e0187630.
    >> Share

  708. KIM GE, Lee JS, Park MH, Yoon JH, et al
    Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma.
    PLoS One. 2017;12:e0187635.
    >> Share

  709. HENDERSON HJ, Karanam B, Samant R, Vig K, et al
    Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival.
    PLoS One. 2017;12:e0189662.
    >> Share

  710. ZEINOMAR N, Thai A, Cloud AJ, McDonald JA, et al
    Alcohol consumption and breast cancer-specific and all-cause mortality in women diagnosed with breast cancer at the New York site of the Breast Cancer Family Registry.
    PLoS One. 2017;12:e0189118.
    >> Share

  711. SYED BM, Morgan D, Setty T, Green AR, et al
    Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.
    PLoS One. 2017;12:e0188528.
    >> Share

  712. FATIMA I, El-Ayachi I, Taotao L, Lillo MA, et al
    The natural compound Jatrophone interferes with Wnt/beta-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
    PLoS One. 2017;12:e0189864.
    >> Share

  713. SOBRAL-LEITE M, Lips EH, Vieira-Monteiro HA, Giacomin LC, et al
    Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.
    PLoS One. 2017;12:e0189750.
    >> Share

  714. DABI Y, Darrigues L, Pons K, Mabille M, et al
    Incidence of inflammatory breast cancer in patients with clinical inflammatory breast symptoms.
    PLoS One. 2017;12:e0189385.
    >> Share

  715. LIU CY, Lau KY, Hsu CC, Chen JL, et al
    Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells.
    PLoS One. 2017;12:e0189007.
    >> Share

  716. RUMNEY RMH, Coffelt SB, Neale TA, Dhayade S, et al
    PyMT-Maclow: A novel, inducible, murine model for determining the role of CD68 positive cells in breast tumor development.
    PLoS One. 2017;12:e0188591.
    >> Share

  717. FIOCCHETTI M, Cipolletti M, Marino M
    Compensatory role of Neuroglobin in nervous and non-nervous cancer cells in response to the nutrient deprivation.
    PLoS One. 2017;12:e0189179.
    >> Share

  718. CATTANEO ER, Prieto ED, Garcia-Fabiani MB, Montanaro MA, et al
    Glycerol-3-phosphate acyltransferase 2 expression modulates cell roughness and membrane permeability: An atomic force microscopy study.
    PLoS One. 2017;12:e0189031.
    >> Share

  719. CARNESECCHI J, Cerutti C, Vanacker JM, Forcet C, et al
    ERRalpha protein is stabilized by LSD1 in a demethylation-independent manner.
    PLoS One. 2017;12:e0188871.
    >> Share

  720. BENNANI-BAITI B, Dietzel M, Baltzer PA
    MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications.
    PLoS One. 2017;12:e0188679.
    >> Share

  721. DENIZ S, Kurt B, Oguzoncul AF, Nazlican E, et al
    Knowledge, attitudes and behaviours of women regarding breast and cervical cancer in Malatya, Turkey.
    PLoS One. 2017;12:e0188571.
    >> Share

  722. ORTIZ AB, Garcia D, Vicente Y, Palka M, et al
    Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
    PLoS One. 2017;12:e0188068.
    >> Share

  723. JIN D, Lee H
    FGMD: A novel approach for functional gene module detection in cancer.
    PLoS One. 2017;12:e0188900.
    >> Share

  724. PAUL B, Royston KJ, Li Y, Stoll ML, et al
    Impact of genistein on the gut microbiome of humanized mice and its role in breast tumor inhibition.
    PLoS One. 2017;12:e0189756.
    >> Share

  725. HANLEY JA, Hannigan A, O'Brien KM
    Mortality reductions due to mammography screening: Contemporary population-based data.
    PLoS One. 2017;12:e0188947.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016